bismuth has been researched along with salicylates in 460 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 110 (23.91) | 18.7374 |
| 1990's | 178 (38.70) | 18.2507 |
| 2000's | 103 (22.39) | 29.6817 |
| 2010's | 53 (11.52) | 24.3611 |
| 2020's | 16 (3.48) | 2.80 |
| Authors | Studies |
|---|---|
| Castellion, AW; Goldenberg, MM; Honkomp, LJ | 1 |
| Ackerman, PB; DuPont, HL; Haynes, G; Pickering, LK; Sullivan, P | 1 |
| DuPont, HL; Ericsson, CD; Evans, DG; Evans, DJ; Pickering, LK | 1 |
| Gyles, CL; Zigler, M | 1 |
| Annexton, M | 1 |
| Albert, KS; DeSante, KA; DiSanto, AR; Welch, RD | 1 |
| Berezovskaia, IV | 1 |
| Bird, N; Butcher, GP; Haqqani, MT; Hughes, SJ; Rhodes, JM; Ryder, SD; Stewart, M | 1 |
| Abbott, PV; Limkangwalmongkol, S; Sandler, AB | 1 |
| Aguade-Bruix, S; Brau-Aguade, E; Canalda-Sahli, C; Sentis-Vilalta, J | 1 |
| Bär, W; Freise, J; Gebel, M; Gladziwa, U; Haruma, K; Lange, P; Schmidt, FW; Wagner, S | 1 |
| Kawanishi, G; Mizuno, A; Ueda, M | 1 |
| Cunha, BA; Domenico, P; O'Leary, R | 1 |
| Laine, L | 1 |
| Oguntebi, BR; Shen, C | 1 |
| Barkin, JS; Bernstein, D | 1 |
| Duriex, DE; Madan, E; Midkiff, BR; Subik, MA; Westblom, TU | 1 |
| Berastegui, E; Brau, E; Canalda, C; Jiménez de Anta, MT; Pumarola, J | 1 |
| Cave, DR | 1 |
| Gump, DW; Hendricks, GM; Meyer, DH; Nadeau, OW | 2 |
| Goldman, M; Kabani, S; Molloy, D; White, RR | 1 |
| Fraser, AG; Lam, WM; Luk, YW; Pounder, RE; Prewett, EJ | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Saeed, ZA | 1 |
| Treem, WR | 1 |
| Keystone, JS; Tellier, R | 1 |
| Glassman, MS | 1 |
| Hudson, M; Lewin, JF; Nwokolo, CU; Pounder, RE | 1 |
| Alpert, LC; Evans, DG; Evans, DJ; Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM | 1 |
| Casaubón-Garcín, P; Cervantes, R; Ramírez-Mayans, J; Tovar-Calderón, S | 1 |
| Bär, W; Gebel, M; Haruma, K; Lange, P; Müller, MJ; Schorn, T; Soudah, B; Varrentrapp, M; Wagner, S | 1 |
| Abbott, PV; Bishop, BM; Burtscher, P; Limkangwalmongkol, S; Sandler, AB | 1 |
| Sainsbury, SJ | 1 |
| Cunha, BA; Domenico, P; Landolphi, DR | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM | 1 |
| Alpert, LC; Evans, DG; Evans, DJ; Graham, DY; Jerdack, GR; Klein, PD; Morgan, DR; Opekun, A | 1 |
| Hudson, M; Nwokolo, CU; Pounder, RE; Prewett, EJ; Sawyerr, AM | 1 |
| ElDeeb, ME; Gettleman, BH; Messer, HH | 1 |
| Farthing, MJ | 1 |
| Bokemeyer, B; Freise, J; Fritsch, RS; Iserhard, R; Schmidt, FW; Soudah, B; Wagner, S; Weissbrodt, H | 1 |
| Avendaño, P; Balm, TK; Braun, SD; Manhart, MD; O'Ryan, M; Soriano, HA; Soriano-Brücher, H | 1 |
| Ali, MR; Blaser, MJ; Morris, AJ; Nicholson, GI; Perez-Perez, GI | 1 |
| Avunduk, C; Eastwood, GL; Gang, D; Polakowski, N; Suliman, M | 1 |
| Korsten, MA; Lateef, SK; Lieber, CS; Paronetto, F; Uppal, R | 1 |
| Campbell, AN | 1 |
| Bolton, RA | 1 |
| Arnold, HL | 1 |
| Jones, H; Rhodes, JM; Ryder, SD; Walker, RJ | 1 |
| Mistry, P; Nwokolo, CU; Pounder, RE | 1 |
| Chaparala, RC; Hakki, FZ; Harmon, JW; Huesken, J; Saini, N; Schweitzer, EJ; Tay, HP | 1 |
| Ahmed, W; Alam, SM; Jafarey, NA; Kazi, AM; Kazi, JI; Qureshi, H; Zuberi, SJ | 1 |
| Brook, AM; Meryon, SD | 1 |
| Cruz Luna, A; DuPont, HL; DuPont, MW; Ericsson, CD; Flores Sanchez, J; Mathewson, JJ; Mendiola Gomez, J | 1 |
| Ferrell, L; Heyman, MB; Ostroff, JW; Veereman Wauters, G | 1 |
| Holtz, TH; Nettleman, MD | 1 |
| Islam, S; McLean, AJ | 1 |
| Hoffman, RS; Mendelowitz, PC; Weber, S | 1 |
| Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Opekun, A | 1 |
| Burnett, JW | 1 |
| Hänninen, ML | 1 |
| Blessing, J; Raedsch, R; Walter-Sack, I; Weber, E | 1 |
| Appelman, HD; Cotner, EK; Elta, GH; Montbriand, JR; Nostrant, TT | 1 |
| Derksen, FJ; Evans, MG; Slocombe, RF | 1 |
| Bonamico, M; Carpino, F; Chiesa, C; Medici, A | 1 |
| Jakobsen, A; Ostergaard, K; Sommer, S; Steiness, E; Thorling, EB | 1 |
| Negm, MM | 1 |
| Bayerdörffer, E; Mannes, GA; Pfaller, P; Sauerbruch, T | 1 |
| McNulty, CA | 2 |
| Axon, AT | 1 |
| Olson, CA; Sox, TE | 1 |
| Bär, W; Freise, J; Fritsch, S; Schmidt, FW; Wagner, S | 1 |
| Barner, M; Emde, C; Hopert, R; Riecken, EO; Vallo-Wermes, M | 1 |
| Appelman, H; Barnett, JL; Behler, EM; Elta, GH; Kern, S; Murphy, R; Nostrant, TT | 1 |
| Lanza, FL; Rack, MF; Skoglund, ML; Yardley, JH | 1 |
| Kraus, JW; Morello, PJ | 1 |
| Hahn, H; Vogt, K; Warrelmann, M | 1 |
| Bästlein, C; Bayerdörffer, E; Kasper, G; Ottenjann, R; Simon, T | 1 |
| Balm, TK; DuPont, HL; Ericsson, CD; Helminger, A; Mathewson, JJ; Steffen, R; Witassek, F; Wolff, K | 1 |
| Shanbrom, E | 1 |
| Szap, MD | 1 |
| Alpert, LC; Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Michaletz, PA; Opekun, AR; Polasani, RR; Smith, KE; Yoshimura, HH | 1 |
| Börsch, G; Rühl, GH | 1 |
| Klostermann, GF | 1 |
| Knowlton, DR; Sander, DS; Ward, RL | 1 |
| Dettmer, A; Eberhardt, R; Hagena, D; Höchter, W; Kasper, G | 1 |
| Crump, B; Davis, M; Donovan, IA; Gearty, JC; Lister, DM; McNulty, CA; Melikian, V; Wise, R | 1 |
| Börsch, G; Mai, U; Müller, KM | 1 |
| Baczako, K; Bode, G; Ditschuneit, H; Malfertheiner, P; Stanescu, A | 1 |
| Chiasson, D; Cutz, E; Drumm, B; Karmali, M; Sherman, P | 1 |
| DuPont, HL | 2 |
| Gregor, M; Hofmann, J; Menge, H | 1 |
| Daschner, F; Engels, I; Kappstein, I; Krieg, N; Pfisterer, J; Reuschenbach, K; Vogel, W | 1 |
| Baczako, K; Bode, G; Ditschuneit, H; Malfertheiner, P; Stanescu, A; Vanek, E | 1 |
| Nakamura, H | 1 |
| DuPont, HL; Helminger, A; Heusser, R; Manhart, MD; Schär, M; Steffen, R; Witassek, F | 1 |
| Girard, DE; Keeffe, EB | 1 |
| Andersen, LP; Andreasen, JJ | 1 |
| Engels, I; Kappstein, I | 1 |
| Rösch, W | 1 |
| Hughes, RJ | 1 |
| Bitsura, JA; de la Cabada, FJ; DuPont, HL; DuPont, MW; Ericsson, CD; Johnson, PC | 1 |
| León-Barúa, R; Tello-Casanova, R | 1 |
| Kreider, S; Lange, WR | 1 |
| Du Pont, HL | 1 |
| Grill, B; Gryboski, JD; Hillemeier, AC; Kocoshis, S | 1 |
| Graham, DY | 1 |
| Bitsura, JA; DuPont, HL; Ericsson, CD; Johnson, PC; Morgan, DR; Wood, LV | 1 |
| Plank, WM | 1 |
| Samková, M | 1 |
| Abbott, DD; Brogle, RC; Harrisson, JW | 1 |
| Kaye, S | 1 |
| Hanke, H; Süss, W | 1 |
| Turner, AC | 1 |
| Weiss, BD | 2 |
| Barriere, SL; Kapusnik, JE | 1 |
| Estes, MK; Gentry, LO; Graham, DY | 1 |
| Hailey, FJ; Newsom, JH | 1 |
| Feldman, M | 1 |
| Ghent, CN; Gryboski, JD; Kocoshis, SA | 1 |
| McIntyre, RV | 1 |
| Stek, M | 1 |
| Levine, RA | 1 |
| Branstetter, J; von Fraunhofer, JA | 1 |
| Fuse, E | 1 |
| Boise, KL; Brooks, RR; Goldenberg, MM | 1 |
| Stillman, AE | 1 |
| Scott, D | 1 |
| Ackerman, PB; DuPont, HL; Ericsson, CD; Evans, DG; Evans, DJ; Pickering, LK; Sullivan, P; Tjoa, WS; Vollet, JJ | 1 |
| Gorbach, SL | 1 |
| Hatogai, H; Ito, A; Mitomo, K; Nakagawa, K; Okada, T; Shima, S; Takahashi, H; Yasuhiro, A | 1 |
| Cleary, TG; Ericsson, CD; Feldman, S; Pickering, LK | 2 |
| Arndt, WF; Burns, JM | 1 |
| Marsh, AP; McPhee, MS | 1 |
| Duggan, JM; Hasking, GJ | 1 |
| Chen, SL; Cleary, TG; Ericsson, CD; Feldman, S; Hulse, M; Pickering, LK | 1 |
| Callahan, DR; Douglas, RG; Greenberg, HB; Steinhoff, MC | 1 |
| DuPont, HL; Ericsson, CD; Pickering, LK; Sullivan, P | 1 |
| Henderson, IW | 1 |
| Georgopoulou, MK; Nikolaou, A; Wesselink, PR; Wu, MK | 1 |
| Horning, TG; Kessler, JR | 1 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
| Dettmer, A; Domschke, W; Fenner, T; Gregor, M; Hesse, P; Holtmann, G; Miederer, SE; Schentke, KU; Schütz, E; van Husen, N | 1 |
| Wilson, WH | 1 |
| Economides, N; Kolokuris, I; Kotsaki-Kovatsi, VP; Poulopoulos, A; Rozos, G; Shore, R | 1 |
| Appelman, HD; Barnett, JL; Behler, EM; Crause, I; Elta, GH; Nostrant, TT; Scheiman, JM | 1 |
| Odell, E; Pertl, C | 1 |
| Asnicar, MA; Chong, SK; Croffie, JM; Fitzgerald, JF; Lee, CH; Lou, Q; Zimmerman, SE | 1 |
| Rampal, P; Scarpignato, C | 1 |
| Dwarakanath, AD; Hart, CA; Milton, JD; Rhodes, JM; Tsai, HH | 1 |
| Cohen, MH | 1 |
| De Gee, AJ; Wesselink, PR; Wu, MK | 1 |
| Gallicano, K; Garber, G; Oliveras, L; Rambout, L; Sahai, J | 1 |
| Rhoads, JM | 1 |
| Barbin, EL; Fidel, RA; Pécora, JD; Sousa Neto, MD; Spanó, JC | 1 |
| Estrela, C; Figueiredo, JA; Pesce, HF; Sidney, GB | 1 |
| al-Assi, MT; Cole, RA; Genta, RM; Graham, DY; Karttunen, TJ | 1 |
| Allen, A; Copeman, M; Dettmar, PW; Leonard, AJ; Matuz, J; Pearson, JP | 1 |
| Bakaletz, LO; Guerrant, RL; Hua, TH; Kunin, CM | 1 |
| Bertrams, J; Börsch, G; Labenz, J; Rühl, GH | 1 |
| Abrams, RI; Barr, WB; Correa, DD; Gordon, MF; Rubin, DB | 1 |
| Campbell, DR; Cherian, R; McGregor, DH; Weston, AP | 1 |
| Graham, DY; Peura, DA | 1 |
| al-Assi, MT; Genta, RM; Graham, DY; Lew, GM; Ramirez, FC | 1 |
| Bleck, J; Gebel, M; Gladziwa, U; Haruma, K; Manns, M; Schmidt, H; Soudah, B; Wagner, S | 1 |
| Höök-Nikanne, J; Kosunen, TU; Roine, RP; Salaspuro, M; Salmela, KS | 1 |
| Berman, D; George, J; Groisman, GM; Harpaz, N | 1 |
| McGuffey, EC | 1 |
| Bellucci, AG; Vernace, MA; Wilkes, BM | 1 |
| Börsch, G; Labenz, J | 1 |
| Correa, P; Fontham, ET; Hunter, FM; Johnson, WD; Malcom, GT; Rood, JC; Ruiz, B; Sobhan, M | 1 |
| Jungreis, AC; Schaumburg, HH | 1 |
| Brazer, SR; Maniatis, AG | 1 |
| Genta, RM; Go, MF; Graham, DY; Lew, GM; Rehfeld, JF | 1 |
| Correa, P; Fontham, E; Hunter, FM; Ruiz, B; Samloff, IM; Sobhan, M | 1 |
| Abramson, JS; Givner, LB; Woods, CR | 1 |
| Guiraldes, E | 1 |
| Levy, G | 1 |
| Graham, DY; Hepps, KS; Lew, GM; Ramirez, FC; Saeed, ZA | 1 |
| Hassall, E; Israel, DM | 1 |
| Börsch, G; Gyenes, E; Labenz, J; Rühl, GH | 2 |
| Cohen, H; Dooley, CP; Field, LG; Frierson, HF; Guerrant, RL; Jerdack, GR; Marshall, BJ; McCallum, RW; Mitra, S; Valenzuela, JE | 1 |
| Fedotin, MS | 1 |
| Cutler, AF; Schubert, TT | 1 |
| Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Ramirez, FC | 1 |
| Campos-Sánchez, M; Eyzaguirre-Maccan, E; Figueroa-Quintanilla, D; León-Barúa, R; Sack, RB; Salazar-Lindo, E; Sarabia-Arce, S | 1 |
| Snyder, JD | 1 |
| Bästlein, E; Bayerdörffer, E; Heldwein, W; Höchter, W; Lehn, N; Mannes, GA; Miehlke, S; Müller-Lissner, S; Sommer, A; Weingart, J | 1 |
| Boersma, J; Wesselink, PR; Wu, MK | 1 |
| Fraga, RC; Garcia, PF; Siqueira, JF | 1 |
| Chandler, NP; Heling, I | 1 |
| Burrow, JA; Clark, CK; Merritt, AM; Steible, CK | 1 |
| Horowitz, NS; Palker, TJ; Staats, HF | 1 |
| Acuña, R; Albornoz, V; Figueroa, G; Portell, DP; Toledo, MS; Troncoso, M; Vigneaux, J | 1 |
| Tytgat, GN | 1 |
| Bästlein, E; Bayerdörffer, E; Bolle, KH; Hatz, R; Heldwein, W; Höchter, W; Klann, H; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Ruckdeschel, G; Simon, T; Sommer, A; Stolte, M; Weingart, J | 1 |
| Fuhrer, J; Hearney, EG; Marioz, P | 1 |
| Braga, PC; Brenciaglia, MI; Dubini, F; Fornara, AM; Scaltrito, MM | 1 |
| Behler, EM; Chey, WD; Crause, I; Elta, GH; Scheiman, JM | 1 |
| Carnes, DL; Del Rio, CE; Esberard, RM | 1 |
| Bästlein, E; Bayerdörffer, E; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Stolte, M | 1 |
| Carmichael, JM; Patchin, GM; Wieland, KA | 1 |
| Freston, JW; Murphy, K; Taylor, JL; Zagari, M | 1 |
| Brown, PW; Chang, J; Hwang, KK; Rao, N; Yerino, P | 1 |
| Seifrit, B | 1 |
| Lambert, JR; Midolo, P | 1 |
| Damianos, AJ; McGarrity, TJ | 1 |
| Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
| Angeletti, S; Annibale, B; Bordi, C; Delle Fave, G; Malagnino, F; Mancino, C; Marignani, M | 1 |
| Danziger, LH; Meyer, JM; Pendland, SL; Ryu, S | 1 |
| Carryl, OR; Guth, PH; Kaunitz, JD; Tanaka, S | 1 |
| Faccioli, LH; Figueiredo, F; Leonardo, MR; Silva, LA | 1 |
| Myers, D | 1 |
| Contreras-Ruiz, J; Guevara-Flores, A; López-Corella, E; Ruiz-Maldonado, R; Sierra-Santoyo, A | 1 |
| Barnett, JL; Chey, WD; DelValle, J; Elta, GH; Fisher, L; Hasler, WL; Nostrant, T; Scheiman, JM | 1 |
| Bagchi, D; Bagchi, M; Carryl, OR; Krohn, RL; Mitra, S; Ray, SD; Stohs, SJ; Tran, MX; Vuchetich, PJ | 1 |
| El-Zaatari, F; Engstrand, L; Genta, RM; Graham, D; Scheynius, A | 1 |
| el-Zimaity, HM; Graham, DP; Graham, DY; Hoffman, J; Osato, M | 1 |
| Eaton, KA; Kramer, LW; Wack, RF | 1 |
| Batchelder, M; Fox, JG; Hayward, A; Murphy, JC; Palley, L; Shames, B; Yan, L | 1 |
| Bierman, JC; Blanchard, TG; Czinn, SJ; Diters, RW; Leunk, RD | 1 |
| Emami, S; Estrada, R; Laine, L; Trujillo, M | 1 |
| Minocha, A; Srinivasan, R | 1 |
| Carrazco, J; Checkley, W; Cordero, L; Gilman, RH; Leon-Barua, R; McDonald, J; Ramirez-Ramos, A; Recavarren-Arce, S; Salazar, G; Valdez, Y; Watanabe, J | 1 |
| Clendening, CE; Dansereau, RJ; Deepe, GS; Dunn, AB; Healy, DP; Mounts, AW | 1 |
| Fine, KD; Lee, EL | 1 |
| Assed, S; da Silva, LA; da Silva, RS; Guimarães, LF; Leonardo, MR | 1 |
| Hansen, MG | 1 |
| Berg, DE; Blaser, MJ; Dubois, A; Fiala, N; Heman-Ackah, LM; Perez-Perez, GI | 1 |
| Ariano, RE; Tkach, CL | 1 |
| Furne, JK; Levitt, MD; Springfield, J; Suarez, FL | 1 |
| Assed, S; Ether, SS; Leonardo, MR; Silva, LA; Utrilla, LS | 1 |
| Geurtsen, W; Krage, T; Leinenbach, F; Leyhausen, G | 1 |
| Matsumoto, K; Ono, K | 1 |
| Ericsson, CD | 1 |
| Carryl, OR; Illich, PA; Lichtenberger, LM; Romero, JJ; Walters, ET | 1 |
| Fitzgerald, JF; Troncone, R | 1 |
| Ahsan, K; Hadjiyane, C; Karakurum, A; Mohammed, I; Nawaz, A; Pellecchia, C | 1 |
| Bellin, EY; Fletcher, DD; Shuter, J; Simone, VJ | 1 |
| Leonardo, MR; Silva, LA; Tanomaru Filho, M; Utrilla, LS | 1 |
| Bello, H; Dominguez, M; Gonzalez, G; Martínez, MA; Mella, S; Pinto, ME; Ruiz, M; Sepulveda, M; Zemelman, R | 1 |
| Surawicz, C | 1 |
| DiBaise, JK; Dy, RM; Lof, J; Quigley, EM | 1 |
| Blanchard, J; Boden, J; Ermak, T; Georgakopoulos, K; Giannasca, P; Gray, H; Hill, J; Ingrassia, J; Kleanthous, H; Lee, CK; Monath, TP; Soike, K; Tibbitts, T; Weltzin, R | 1 |
| de Uzeda, M; Lopes, HP; Rôças, IN; Siqueira, JF | 1 |
| Anderson, SY; Graham, DY; Lang, T | 1 |
| Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL | 1 |
| Cabanillas, FF; Ford, R; Genta, RM; Glober, G; Graham, DY; Hagemeister, FB; Johnson, CM; Lahoti, S; Lee, JE; Luthra, R; Lynch, PM; Manning, JT; McLaughlin, PW; Rodriguez, MA; Romaguera, JE; Sample, D; Sarris, AH; Shen, Y; Steinbach, G; Winn, RJ; Younes, A | 1 |
| Fendrich, Z | 1 |
| Bagchi, D; Bagchi, DJ; Bagchi, M; Balmoori, J; Carryl, OR; Garg, A; Milnes, MM; Mitra, S; Stohs, SJ; Tran, MX; Williams, CB | 1 |
| Bravo, LE; Campo, C; Correa, P; Mera, R; Realpe, JL | 1 |
| Coyle, WJ; Duntemann, T; Lawson, JM; Murphy, M; Nemec, R; Peterson, R; Sedlack, RE | 1 |
| Canning, A; Egan, C; Farraye, FA; Kemp, JA; Lee, M; Tataronis, G | 1 |
| Schiller, LR | 2 |
| Shlim, DR | 1 |
| Dubois, A; Heman-Ackah, LM; Mysore, JV; Simon, PM; Wigginton, T; Zopf, D | 1 |
| Alonso García, I; García Pérez, A; Giménez Samper, M; Valverde de La Osa, J | 1 |
| Bagchi, D; Bagchi, M; Balmoori, J; Carryl, OR; Kuszynski, CA; McGinn, TR; Mitra, S; Stohs, SJ; Ye, X | 1 |
| Jayalatha, NS; Kuriakose, S; Saradadevi, KL | 1 |
| Economides, N; Tziafas, D | 1 |
| Gurer, I; Hilmioglu, F; Ozyilkan, E; Sare, M; Taskin, V | 1 |
| Bravo, JC; Bravo, LE; Correa, P; Realpe, JL; Ruiz, B; van Doorn, LJ | 1 |
| Brousal, A; Kearney, DJ | 1 |
| Cleary, CE; Malatjalian, DA; Peterson, TC; Shaw, AM; Veldhuyzen van Zanten, SJ | 1 |
| Bisson, S; Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD | 1 |
| Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Kwon, DH; Opekun, AR; Osato, MS | 1 |
| Ewing, SL; Furne, JK; Levitt, MD; Springfield, J; Suarez, FL | 1 |
| Furne, J; Garten, C; Levitt, MD; Stiehm, J; Suarez, FL | 1 |
| Amaro, R; Poniecka, A; Rogers, AI | 1 |
| Levitt, MD; Suarez, FL | 1 |
| García, A; González, C; Solar, H; Zemelman, R | 1 |
| Devitt, NF | 1 |
| Chiba, N | 1 |
| Carlos, IZ; Consolaro, A; Leonardo, MR; Leonardo, RT | 1 |
| Gettleman, L; Goldsmith, LJ; Mayhew, JT; Windchy, AM | 1 |
| de Souza, LC; Demarchi, AC; Duarte, MA; Fraga, SC; Giaxa, MH; Kuga, MC | 1 |
| Bonifácio, KC; da Silva, LA; Ito, IY; Leonardo, MR; Tanomaru Filho, M | 1 |
| El-Zimaity, HM; Graham, DY; Hoffman, J; Kwon, DH; Osato, MS; Saeed, MA | 1 |
| Fan, B; Wesselink, PR; Wu, MK | 1 |
| Bravo, JC; Bravo, LE; Casabon, AL; Collazos, T; Correa, P; Fischbach, LA; Ramirez, H; Realpe, JL; Ruiz, B; Schmidt, BA | 1 |
| Bruzzese, E; Guarino, A | 1 |
| Chowdhury, HR; Faruque, SM; Lescano, AG; Rahman, A; Sack, RB; Yunus, M; Zaman, K | 1 |
| Adams, DR; Gordon, CA; Ioffreda, MD; Miller, JJ; Naides, SJ | 1 |
| Boiesen, J; Eriksen, HM; Waltimo, TM; Ørstavik, D | 1 |
| Allan, NA; Schaeffer, MA; Schaffer, A; Walton, RC | 1 |
| Parsons, JR; Ricks-Williamson, L; Walton, RE | 1 |
| Corder, FA; Howden, CW; Sahai, AV; Sharma, VK | 1 |
| Huang, TH; Kao, CT; Lee, H | 1 |
| Ferguson, DB; Hartwell, GR; Marley, JT | 2 |
| Chan, Y; Chang, YC; Chou, MY; Huang, FM; Huang, MS; Lai, CC; Yang, HW | 1 |
| Kollaritsch, H; Rendi-Wagner, P | 1 |
| Chang, YC; Chou, MY; Huang, FM; Tai, KW | 1 |
| Amsler, KM; Foster, LA; Merrill, JJ; Modzelewski, TC; Quispe, JD; Sizemore, CF; Slee, AM; Stevenson, DA | 1 |
| Takahashi, S; Tanaka, A | 1 |
| Bernabé, oF; de Souza, V; Filho, JA; Holland, R; Junior, ED; Murata, SS; Nery, MJ | 1 |
| Hagan, L; Johns, J; More, D; Whisman, B | 1 |
| Hagge, MS; Lindemuth, JS; Wong, RD | 1 |
| Davis, MC; Rivera, EM; Walton, RE | 1 |
| Carvalho-Júnior, JR; Cruz-Filho, AM; Passarinho-Neto, JG; Pécora, JD; Saquy, PC; Sousa-Neto, MD | 1 |
| Fölsch, UR; Hellmig, S; Katsoulis, S; Stüber, E | 1 |
| Michetti, P; Suerbaum, S | 1 |
| Camps, JJ; Lee, KW; Pashley, DH; Williams, MC | 1 |
| Marlier, EM; Thurston, JH; Whitmire, KH | 1 |
| Jeansonne, BG; Layman, D; Neff, T | 1 |
| Chande, N; MacDonald, JK; McDonald, JW | 9 |
| About, I; Camps, J; Pashley, D; Pommel, L | 1 |
| Brugnera-Junior, A; Guerisoli, DM; Pecora, JD; Picoli, F; Saquy, PC | 1 |
| Canzobre, MC; Kaplan, AE; Ormaechea, MF; Picca, M; Ubios, AM | 1 |
| Abdo, AA; Beck, PL; Urbanski, SJ | 1 |
| Correa, P; Feldman, M; Fischbach, LA; Fontham, E; Goodman, KJ; Jain, R; Priest, E | 1 |
| Nielsen, OH; Schaffalitzky de Muckadell, OB | 1 |
| KAYSER, HW | 1 |
| MANGANIELLO, A; NINFO, G | 1 |
| HARVEY, P | 1 |
| MAHER, JF; SCHREINER, GE | 1 |
| LABRAM, C | 1 |
| Cisneros, G; Gurney, M; Jarjoura, D; Lara, LF; Moauro, B; Polen, A; Rutecki, G; Van Ness, M; Whittier, F | 1 |
| Schäfer, E; Zandbiglari, T | 1 |
| Adanir, N; Belli, S; Erdemir, A | 1 |
| Facer, SR; Walton, RE | 1 |
| PARDO, OA; PARDO-CASTELLO, V | 2 |
| KOLMER, JA | 3 |
| APTED, I | 1 |
| HARRINGTON, CM; PAUL, HE | 1 |
| PARDO CASTELLO, V; PARDO, OA | 1 |
| Bacon, K; Deveney, C; Gilster, J; Marlink, K; Rutten, M; Sheppard, B | 1 |
| Abudayyeh, S; Belson, G; Dore, MP; El-Zimaity, HM; Graham, DY; Osato, MS | 1 |
| Burford, N; Eelman, MD; Mahony, DE; Veldhuyzen van Zanten, SJ; Woods, A | 1 |
| Dodge, AG; Wackett, LP | 1 |
| Banks, JB; Devitt, N | 1 |
| Hussne, RP; Nishiyama, CK; Sipert, CR; Torres, SA | 1 |
| Aeed, H; Avni, Y; Birkenfeld, S; Eliakim, R; Levine, A; Shabat-Sehayek, V; Shevah, O; Shirin, H; Wardi, J | 1 |
| Sun, XM; Yang, ZM | 1 |
| Badillo, R; Hagemann, TM; Lewis, TV; McGoodwin, L; Schaeffer, S | 1 |
| Hanjani, NM; Rencic, A; Whitmore, SE | 1 |
| DuPont, HL; Koo, HL | 1 |
| Leonardo, MR; Luis, MR; Silva, LA; Tanomaru, JM; Tanomaru-Filho, M | 1 |
| Andrews, PC; Deacon, GB; Forsyth, CM; Junk, PC; Kumar, I; Maguire, M | 1 |
| Choe, YH; Choi, J; Jang, JY; Kim, JS; Kim, KM; Park, HY | 1 |
| Fagin, B; Feeman, W; Lash, A; Wismer, T | 1 |
| Page, MJ; Schirmer, LL; Wall, GC | 1 |
| Burford, N; Eelman, MD; Phillips, HA | 1 |
| Harper, DS | 1 |
| Gonçalves, M; Jorge, EG; Tanomaru, JM; Tanomaru-Filho, M | 1 |
| Hwang, KK; Kim, NR; Lee, DH; Lee, YK; Lim, BS; Yang, HC | 1 |
| Birkenfeld, G | 1 |
| Bravo, JC; Bravo, LE; Camargo, MC; Ceron, C; Correa, P; Delgado, AG; Fontham, ET; Mera, RM; Piazuelo, MB; Yepez, MC | 1 |
| Flint, KP; Naghdi, S; Raheb, J | 1 |
| Sökeland, J | 1 |
| Dunzendorfer, T; Johnson, R; Wilkins, S | 1 |
| Kurtz, SM; Manley, MM; Rimnac, CM; Sobieraj, MC; Wang, A | 1 |
| Archer, LL; Atkins, A; Childress, AL; Citino, SB; Fraser, WA; Wellehan, JF | 1 |
| Hotta, J; Ito, IY; Tanomaru, JM; Tanomaru-Filho, M; Watanabe, E | 1 |
| Al-Tarawneh, SK; Khraisat, A; Mahafzah, A; Salem, A; Smadi, L | 1 |
| Redfield, D; Singh, E | 1 |
| Wang, WQ; Zhang, QH; Zhu, BM | 1 |
| Andrews, PC; Deacon, GB; Ferrero, RL; Junk, PC; Karrar, A; Kumar, I; MacLellan, JG | 1 |
| Bernardineli, N; Bramante, CM; Camargo, EJ; de Moraes, IG; del Carpio Perochena, A; Garcia, RB; Graeff, MS; Gutmann, JL; Ordinola-Zapata, R; Vivan, RR | 1 |
| Bonanato-Estrela, C; Bonetti-Filho, I; Pappen, FG; Shemesh, H; Souza, EM | 1 |
| Cohen, PR | 1 |
| Gutierrez, AM; Jhala, N; Malik, TA; Peter, S | 1 |
| Chen, F; Liu, C; Mao, Y | 1 |
| HILL, JS; SCHMITZ, RE | 1 |
| EAGLE, H | 1 |
| LEWIS, GM | 1 |
| Chey, WD; Malfertheiner, P; Vakil, N | 1 |
| GROSSMAN, HD | 2 |
| George, AE; Hildebrandt, E; Horton, KE; McGee, DJ; Testerman, TL; Trainor, EA | 1 |
| Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S | 1 |
| André, V; Curfs, C; Duarte, MT; Duer, MJ; Friščić, T; Halasz, I; Hardeman, A; Jackson, GJ; Reid, DG; Stein, RS | 1 |
| Alfredo, E; Cunha, SA; León, JE; Perez, DE; Rached, FJ | 1 |
| Borges, RP; De-Deus, G; Miranda, CE; Pécora, JD; Rached-Júnior, FA; Sousa-Neto, MD; Versiani, MA | 1 |
| Başer, O; Emer, O; Kadayifci, A; Kantarcioğlu, M; Kılcıler, G; Ozcan, A; Polat, Z; Uygun, A | 1 |
| Fu, Y; Gao, DW; Jones, EF; Mongan, J; Rathnayake, S; Wang, R; Yeh, BM | 1 |
| Tack, J | 1 |
| Wenzl, HH | 1 |
| Joseph, R; Singh, S | 1 |
| Berbert, FL; Faria-Júnior, NB; Guerreiro-Tanomaru, JM; Tanomaru-Filho, M | 1 |
| Adler, M; Dinh, C; Gray, LV; Gutierrez, A; Lu, B; Lukomnik, J; Marton, S; Mirabal, Y; Oden, M; Richards-Kortum, R; Schutze, GE; Shah, K; Slough, T; Spiegel, GJ; Wickham, H; Yeh, PT | 1 |
| Balasanthiran, V; Chisholm, MH; Durr, CB; Gallucci, JC | 1 |
| Abbas, Z; Awan, S; Hamid, S; Jafri, F; Jafri, W; Naz, S; Usman, MW; Yakoob, J | 1 |
| Goldman, RD | 1 |
| Bingham, AL; Brown, RO; Dickerson, RN | 1 |
| Bełtowski, J; Gertler, A; Jamroz-Wiśniewska, A; Solomon, G; Whiteman, M; Wood, ME | 1 |
| Blaine, ET; Johnson, AL; Lewis, AD | 1 |
| Mahachai, V; Siramolpiwat, S; Srinarong, C; Vilaichone, RK; Wongcha-um, A | 1 |
| Britt, TJ; Gross, WR; Montgomerie, SA; Van Metre, RM | 1 |
| Boissy, YL; Lee, D; Park, GW; Pitz, AM; Vinjé, J | 1 |
| Heather, CS | 1 |
| Chan, AT; Colussi, D; Khalili, H; Lauwers, GY; Ricciardiello, L; Richter, JR; Salari, B; Stewart, KO | 1 |
| Mahachai, V; Prapitpaiboon, H; Vilaichone, RK | 1 |
| Duarte, MA; Greatti, VR; Lima, FL; Vivan, RR; Weckwerth, PH | 1 |
| Ataseven, H; Baglıcakoglu, M; Biyik, M; Demir, A; Goktepe, H; Gungor, G; Kayacetin, E; Ucar, R | 1 |
| Cartowski, J; Dart, A; Gupta, A; Gupta, S; Nelson, C; Poddar, A; Ravi, BS; Sheele, J; Stashko, E | 1 |
| Chaithongrat, S; Gamnarai, P; Mahachai, V; Namtanee, J; Prapitpaiboon, H; Vilaichone, RK; Wongcha-um, A | 1 |
| Geboes, K; Jauregui-Amezaga, A; Vermeire, S | 1 |
| Binversie, E; Fessenden, SW; Ruiz-Moreno, M; Stern, MD | 1 |
| Giddings, SL; Leung, DT; Stevens, AM | 1 |
| Alzraikat, H; Hassouneh, L; Taha, NA | 1 |
| Araújo, VL; Cruz Filho, AM; Pécora, JD; Silva, RG; Souza-Gabriel, AE | 1 |
| Fallone, CA; Shaikh, T | 1 |
| Barton, LL; Lin, DM; Lin, HC; Ritz, NL; Wilson, MR | 1 |
| Abbasi, J | 1 |
| Goldberg, D; King, MA; Parker, V | 1 |
| Al Yatama, N; Bhanji, T; Chande, N; MacDonald, JK; McDonald, JW; Nguyen, TM | 1 |
| Almaguer-Flores, A; Aztatzi-Aguilar, OG; Camps, E; De Vizcaya-Ruiz, A; Flores-Castañeda, M; Uribe-Ramírez, M; Vega-Jiménez, AL | 1 |
| Chande, N; Kafil, TS; MacDonald, JK; McDonald, JW; Nguyen, TM; Patton, PH | 1 |
| Göktaş, Z; Kahramanoğlu Aksoy, E; Nazlıgül, Y; Pirinçci Sapmaz, F; Uzman, M | 1 |
| Coşkun, DÖ; Deniz, K; Gürsoy, Ş; Özbakir, Ö; Yagbasan, A; Yücesoy, M | 1 |
| Alpert, L; Colussi, D; Khalili, H; Lauwers, GY; Misdraji, J; Setia, N; Stewart, KO; van der Sloot, KW | 1 |
| Robotis, J; Rokkas, T; Tsiodras, S | 1 |
| Chalkias, S; Edwards, MR; Koulinska, I; Riester, K | 1 |
| Calello, DP; Eustaquio, N; Nelson, LS; Ruck, BE; Santos, C; Yu, C | 1 |
| Hon, KL; Leung, AAM; Leung, AKC; Wong, AHC | 1 |
| Agboatwalla, M; Bowen, A; Brum, J; Pitz, A; Plikaytis, B; Salahuddin, S | 1 |
| Borbinha, C; Salavisa, M; Serrazina, F; Viana-Baptista, M | 1 |
| Balderas-López, JL; Bernad-Bernad, MJ; Medina-Torres, L; Navarrete, A; Orona-Ortiz, A; Pineda-Peña, EA; Tavares Carvalho, JC; Velázquez-Moyado, JA | 1 |
| Cogdill, AG; Guevara, B | 1 |
| Rubin, DT; Wolf, CH; Wolf, DC | 1 |
| Connor, BA; Martin, GJ; Riddle, MS | 1 |
| Araujo, RC; Ciriaco, FM; DiLorenzo, N; Dubeux, JCB; Fontes, PLP; Garcia-Ascolani, ME; Henry, DD; Lamb, GC; Mejia-Turcios, SE; Oosthuizen, N; Rostoll-Cangiano, L; Schulmeister, TM | 1 |
| Araujo, RC; Ciriaco, FM; Cliff Lamb, G; DiLorenzo, N; Dubeux, JCB; Fontes, PLP; Henry, DD; Oosthuizen, N; Rostoll-Cangiano, L; Sanford, CD; Schulmeister, TM | 1 |
| Balan, G; Brum, JM; Gibb, RD; Ramsey, DL; Yacyshyn, BR | 1 |
| Halani, S; Wu, PE | 1 |
| Liang, D; Ma, J; Wei, B | 1 |
| Janssens, L; Ji, H; Khanna, S | 1 |
| Almaguer-Flores, A; Clemente, I; Prado-Prone, G; Rodil, SE; Silva-Bermudez, P; Velasquillo, C; Vidal-Gutiérrez, X | 1 |
| Alaa Eddin, K; Alassi, MW; Alhalabi, M; Cheha, K | 1 |
| Araujo, RC; Ciriaco, FM; DiLorenzo, N; Dubeux, JCB; Henry, DD; Johnson, BJ; Mejia-Turcios, SE; Osorio-Doblado, AM; Sarturi, JO; Urso, PM; Woerner, DR | 1 |
| Arhangelskis, M; Bazhenov, V; Chaumont, D; Del Carmen Marco de Lucas, M; Dippel, AC; Do, JL; Friščić, T; Geoffroy, N; Glaevecke, P; Gutowski, O; Halasz, I; Hudspeth, JM; Ivashko, O; Kimber, SAJ; Meyer, M; Mouhtadi, S; Rousselin, Y; Schwanen, V; Spoerk-Erdely, P; Szczerba, D; Tan, D; Titi, HM | 1 |
| Inge, AK; Nero, M; Rooth, V; Svensson Grape, E; Willhammar, T | 1 |
| Calello, DP; Meaden, CW | 1 |
| Heimer, MM; Yeh, BM | 1 |
57 review(s) available for bismuth and salicylates
| Article | Year |
|---|---|
Therapeutic approaches to recurrent peptic ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Recurrence; Salicylates | 1992 |
Chronic nonspecific diarrhea of childhood.
Topics: Bismuth; Body Water; Breath Tests; Child, Preschool; Chronic Disease; Diagnosis, Differential; Diarrhea, Infantile; Dicyclomine; Dietary Carbohydrates; Fruit; Gastrointestinal Motility; Humans; Infant; Infant, Newborn; Intestinal Diseases, Parasitic; Lactose Intolerance; Loperamide; Malabsorption Syndromes; Myoelectric Complex, Migrating; Organometallic Compounds; Salicylates | 1992 |
Prevention of traveler's diarrhea.
Topics: Anti-Bacterial Agents; Bismuth; Diarrhea; Food Microbiology; Humans; Organometallic Compounds; Risk Factors; Salicylates; Travel; Water Microbiology; Water Supply | 1992 |
Helicobacter pylori infection in children. A clinical overview.
Topics: Anti-Bacterial Agents; Biopsy; Bismuth; Child; Clinical Trials as Topic; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Evaluation Studies as Topic; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Prevalence; Salicylates | 1992 |
[Helicobacter pylori: can it be a contributing factor in peptic ulcer in childhood?].
Topics: Anti-Bacterial Agents; Bismuth; Child; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates | 1991 |
Review article: prevention and treatment of travellers' diarrhoea.
Topics: Anti-Bacterial Agents; Bismuth; Diarrhea; Diet; Fluid Therapy; Humans; Organometallic Compounds; Risk Factors; Salicylates; Travel | 1991 |
Nongenital warts: classification and treatment options.
Topics: Bismuth; Cryosurgery; Humans; Hypnosis; Immunotherapy; Retinoids; Salicylates; Salicylic Acid; Skin Diseases; Warts | 1991 |
Pathogenicity of Campylobacter pylori--a causative factor in gastritis?
Topics: Animals; Antacids; Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Gastritis; Humans; Organometallic Compounds; Salicylates; Salicylic Acid | 1989 |
Campylobacter pylori--therapy review.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Humans; Metronidazole; Organometallic Compounds; Salicylates; Salicylic Acid | 1989 |
Bismuth subsalicylate in the treatment and prevention of diarrheal disease.
Topics: Adolescent; Adult; Bismuth; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Humans; Middle Aged; Organometallic Compounds; Salicylates | 1987 |
[Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
Topics: Bismuth; Campylobacter Infections; Chronic Disease; Dose-Response Relationship, Drug; Gastritis; Humans; Organometallic Compounds; Salicylates | 1987 |
Nonfluid therapy and selected chemoprophylaxis of acute diarrhea.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bismuth; Campylobacter Infections; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Diarrhea, Infantile; Drug Combinations; Dysentery, Amebic; Dysentery, Bacillary; Escherichia coli Infections; Giardiasis; Humans; Infant; Kaolin; Loperamide; Narcotics; Organometallic Compounds; Parasympatholytics; Pectins; Salicylates; Salmonella Infections; Travel | 1985 |
[Filling of drugs into gelatine capsules in pharmacies].
Topics: Acetanilides; Antipyrine; Aspirin; Bicarbonates; Bismuth; Caffeine; Capsules; Codeine; Dosage Forms; Methods; Nitrates; Pharmacies; Phosphates; Quinine; Salicylates; Sodium; Starch; Sulfates; Technology, Pharmaceutical | 1969 |
Traveler's diarrhea.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Campylobacter Infections; Diarrhea; Diet; Dysentery, Bacillary; Escherichia coli Infections; Fluid Therapy; Giardiasis; Humans; Intestines; Organometallic Compounds; Risk; Salicylates; Salmonella Infections; Time Factors; Travel; Vaccination; Vibrio Infections; Vibrio parahaemolyticus | 1984 |
Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.
Topics: Anti-Bacterial Agents; Antibiosis; Antidiarrheals; Bismuth; Clinical Trials as Topic; Diarrhea; Feeding Behavior; Fluid Therapy; Food Microbiology; Humans; Lactobacillus; Organometallic Compounds; Salicylates; Travel; Water Microbiology; Water Supply | 1995 |
Treating peptic ulcer: an ongoing challenge.
Topics: Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline | 1995 |
Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.
Topics: Aged; Amoxicillin; Biopsy; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Ranitidine; Salicylates; Stomach; Stomach Neoplasms | 1994 |
Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
Topics: Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; United States | 1994 |
Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates | 1993 |
Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Monte Carlo Method; Organometallic Compounds; Patient Compliance; Proton Pump Inhibitors; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1997 |
Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 1997 |
The actions of bismuth in the treatment of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Bismuth; Drug Synergism; Duodenum; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Organometallic Compounds; Ranitidine; Salicylates; Treatment Outcome | 1997 |
Treatment strategies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Salicylates; Tetracycline | 1997 |
[Common gastrointestinal symptoms and their effective and safe treatment].
Topics: Bismuth; Cathartics; Dioctyl Sulfosuccinic Acid; Gastrointestinal Diseases; Humans; Organometallic Compounds; Psyllium; Salicylates | 1999 |
Traveler's diarrhea.
Topics: Antibiotic Prophylaxis; Behavior Therapy; Bismuth; Diagnosis, Differential; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel; Vaccines | 1999 |
An understanding of excessive intestinal gas.
Topics: Bismuth; Charcoal; Diagnosis, Differential; Eructation; Flatulence; Humans; Organometallic Compounds; Salicylates | 2000 |
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; MEDLINE; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Risk Factors; Salicylates; Sensitivity and Specificity | 2001 |
[Classic triple therapy for Helicobacter pylori infection].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 2002 |
Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Proton Pump Inhibitors; Ranitidine; Salicylates; Virulence | 2002 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis; Collagen; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2002 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis; Diarrhea; Humans; Organometallic Compounds; Salicylates | 2003 |
Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and management.
Topics: Algorithms; Antidiarrheals; Bismuth; Budesonide; Colitis; Humans; Organometallic Compounds; Salicylates; T-Lymphocytes | 2003 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis; Collagen; Diarrhea; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2003 |
TOXIC NEPHROPATHY.
Topics: Analgesics; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Antipyretics; Arsenic; Bismuth; Cadmium; Carbon Tetrachloride Poisoning; Contrast Media; Glycols; Gold; Heat Exhaustion; Insecticides; Kidney Diseases; Lead Poisoning; Mercury Poisoning; Metals; Poisoning; Radiation Injuries; Salicylates; Sulfonamides; Toxicology; Uranium; Venoms | 1965 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis; Collagen; Diarrhea; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2004 |
Interventions for treating collagenous colitis: a Cochrane Inflammatory Bowel Disease Group systematic review of randomized trials.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chi-Square Distribution; Colitis, Collagenous; Double-Blind Method; Humans; Organometallic Compounds; Prednisolone; Randomized Controlled Trials as Topic; Salicylates | 2004 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis; Collagen; Diarrhea; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2005 |
Travellers' diarrhoea: contemporary approaches to therapy and prevention.
Topics: Anti-Bacterial Agents; Antidiarrheals; Azithromycin; Bismuth; Campylobacter; Clinical Trials as Topic; Diarrhea; Drug Resistance, Bacterial; Escherichia coli; Food Microbiology; Humans; Hygiene; Organometallic Compounds; Rifamycins; Rifaximin; Salicylates; Shigella; Travel; Water Microbiology | 2006 |
Current and future developments in travelers' diarrhea therapy.
Topics: Bismuth; Diarrhea; Fluid Therapy; Humans; Organometallic Compounds; Probiotics; Rifamycins; Rifaximin; Risk Factors; Salicylates; Travel | 2006 |
Interventions for treating collagenous colitis.
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Chronic Disease; Colitis, Collagenous; Diarrhea; Humans; Organometallic Compounds; Probiotics; Randomized Controlled Trials as Topic; Salicylates | 2006 |
Interventions for treating lymphocytic colitis.
Topics: Antidiarrheals; Bismuth; Colitis, Lymphocytic; Humans; Organometallic Compounds; Salicylates | 2007 |
Pharmacotherapy for microscopic colitis.
Topics: Adrenal Cortex Hormones; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Microscopic; Humans; Loperamide; Organometallic Compounds; Salicylates; Treatment Outcome | 2007 |
[Treating travelers' diarrhea. When should medication be given?].
Topics: Adult; Anti-Bacterial Agents; Atropine; Bismuth; Child; Cross-Sectional Studies; Diphenoxylate; Drug Combinations; Dysentery; Fluid Therapy; Fluoroquinolones; Humans; Loperamide; Organometallic Compounds; Probiotics; Risk Factors; Salicylates; Travel | 2007 |
Interventions for treating lymphocytic colitis.
Topics: Antidiarrheals; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Lymphocytic; Humans; Mesalamine; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2008 |
Prophylaxis for travelers' diarrhea.
Topics: Antibiotic Prophylaxis; Antidiarrheals; Bismuth; Diarrhea; Disinfection; Fluid Therapy; Food Contamination; Food Microbiology; Humans; Hygiene; Organometallic Compounds; Risk Factors; Salicylates; Travel; Water Microbiology | 2009 |
Black tongue secondary to bismuth subsalicylate: case report and review of exogenous causes of macular lingual pigmentation.
Topics: Bismuth; Humans; Hyperpigmentation; Male; Middle Aged; Organometallic Compounds; Salicylates; Tongue Diseases | 2009 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Stomach Neoplasms; Tetracycline | 2011 |
Functional diarrhea.
Topics: Antidepressive Agents, Tricyclic; Antidiarrheals; Bismuth; Carbon; Cholestyramine Resin; Chronic Disease; Clonidine; Diarrhea; Humans; Octreotide; Organometallic Compounds; Oxides; Probiotics; Receptors, Opioid; Salicylates; Serotonin 5-HT3 Receptor Antagonists; Thiorphan | 2012 |
Diarrhea in chronic inflammatory bowel diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Bacterial Infections; Biopsy; Bismuth; Blood Cell Count; Blood Chemical Analysis; Body Water; Breath Tests; Budesonide; Cholestyramine Resin; Colitis, Microscopic; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Endoscopy, Gastrointestinal; Feces; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Absorption; Intestinal Fistula; Intestinal Mucosa; Intestines; Ion Transport; Malabsorption Syndromes; Medical History Taking; Mesalamine; Organometallic Compounds; Physical Examination; Postoperative Complications; Prednisolone; Salicylates; Sodium; Tumor Necrosis Factor-alpha | 2012 |
Travellers' diarrhoea.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Diarrhea; Diet; Fluid Therapy; Humans; Organometallic Compounds; Salicylates; Thiorphan; Travel-Related Illness | 2015 |
Contemporary methods for the diagnosis and treatment of microscopic colitis.
Topics: Anti-Inflammatory Agents; Antidiarrheals; Bismuth; Budesonide; Colitis, Microscopic; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mesalamine; Organometallic Compounds; Probiotics; Risk Factors; Salicylates; Tumor Necrosis Factor-alpha | 2016 |
Traveler's Diarrhea.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antidiarrheals; Arthritis, Reactive; Bismuth; Dehydration; Diarrhea; Female; Fluid Therapy; Foodborne Diseases; Guillain-Barre Syndrome; Humans; Immunocompromised Host; Irritable Bowel Syndrome; Organometallic Compounds; Pregnancy; Probiotics; Risk Factors; Salicylates; Travel; Travel Medicine; Vaccines; Waterborne Diseases | 2016 |
Interventions for treating lymphocytic colitis.
Topics: Anti-Inflammatory Agents; Antidiarrheals; Beclomethasone; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Lymphocytic; Humans; Mesalamine; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2017 |
Interventions for treating collagenous colitis.
Topics: Bismuth; Boswellia; Budesonide; Cholestyramine Resin; Chronic Disease; Colitis, Collagenous; Diarrhea; Glucocorticoids; Humans; Mesalamine; Organometallic Compounds; Plant Extracts; Prednisolone; Probiotics; Randomized Controlled Trials as Topic; Salicylates | 2017 |
Travelers' Diarrhea: A Clinical Review.
Topics: Anti-Bacterial Agents; Azithromycin; Bismuth; Dehydration; Developing Countries; Dysentery; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Food Contamination; Health Knowledge, Attitudes, Practice; Humans; Loperamide; Organometallic Compounds; Patient Education as Topic; Salicylates | 2019 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea.
Topics: Bismuth; Communicable Diseases; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 2021 |
90 trial(s) available for bismuth and salicylates
| Article | Year |
|---|---|
Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university.
Topics: Bismuth; Clinical Trials as Topic; Diarrhea; Drug Combinations; Dysentery, Bacillary; Escherichia coli Infections; Humans; Mexico; Placebos; Salicylates; Students | 1977 |
New remedy for traveler's diarrhea.
Topics: Bismuth; Clinical Trials as Topic; Diarrhea; Humans; Mexico; Salicylates; Travel; United States | 1978 |
The apical seal of root canal sealing cements using a radionuclide detection technique.
Topics: Administration, Topical; Analysis of Variance; Anti-Inflammatory Agents; Bismuth; Calcium Hydroxide; Dental Cements; Dental Leakage; Dexamethasone; Drug Combinations; Epoxy Resins; Evaluation Studies as Topic; Formaldehyde; Gamma Cameras; Humans; Hydrocortisone; Methenamine; Polyvinyls; Radionuclide Imaging; Resins, Synthetic; Root Canal Filling Materials; Salicylates; Silver; Sodium Pertechnetate Tc 99m; Thymol; Titanium; Tooth Root; Zinc Oxide; Zinc Oxide-Eugenol Cement | 1992 |
Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.
Topics: Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Salicylates; Time Factors | 1992 |
Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection.
Topics: Bismuth; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Pain Measurement; Salicylates | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Risk Factors; Salicylates; Stomach Ulcer; Tetracycline | 1992 |
The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates | 1991 |
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Salicylates; Single-Blind Method; Tetracycline | 1991 |
The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds.
Topics: Adult; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Humans; Intestinal Absorption; Male; Organometallic Compounds; Placebos; Ranitidine; Receptors, Histamine H2; Salicylates | 1991 |
Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study.
Topics: Acute Disease; Bismuth; Child, Preschool; Diarrhea, Infantile; Double-Blind Method; Escherichia coli Infections; Feces; Fluid Therapy; Humans; Infant; Length of Stay; Organometallic Compounds; Rotavirus Infections; Salicylates | 1991 |
Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori.
Topics: Adult; Alcoholism; Aluminum Hydroxide; Amoxicillin; Bismuth; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Salicylates; Temperance | 1991 |
A placebo controlled trial of bismuth salicylate in Helicobacter pylori associated gastritis.
Topics: Adolescent; Adult; Bismuth; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Placebos; Prospective Studies; Salicylates; Salicylic Acid | 1990 |
Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea.
Topics: Acute Disease; Adult; Bismuth; Clinical Trials as Topic; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Loperamide; Male; Nonprescription Drugs; Organometallic Compounds; Piperidines; Salicylates | 1990 |
[Epidemiology and therapy of Campylobacter pylori infection].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Drug Evaluation; Drug Therapy, Combination; Duodenum; Female; Gastrointestinal Diseases; Gastroscopy; Germany, West; Humans; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Salicylates; Stomach | 1989 |
[The effect of a calcium carbonate-bismuth subsalicylate combination on intragastric acidity over the course of 24 hours. A randomized study of healthy probands].
Topics: Adult; Bismuth; Calcium Carbonate; Circadian Rhythm; Drug Therapy, Combination; Female; Gastric Acidity Determination; Humans; Male; Organometallic Compounds; Salicylates | 1989 |
The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
Topics: Bismuth; Campylobacter; Campylobacter Infections; Gastritis; Humans; Organometallic Compounds; Prospective Studies; Random Allocation; Salicylates | 1989 |
Bismuth/ofloxacin combination for duodenal ulcer.
Topics: Anti-Infective Agents; Bismuth; Campylobacter Infections; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Humans; Ofloxacin; Organometallic Compounds; Oxazines; Random Allocation; Salicylates | 1987 |
Travelers' diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy.
Topics: Aeromonas; Africa, Western; Animals; Bismuth; Cryptosporidium; Diarrhea; Entamoeba histolytica; Escherichia coli; Feces; Female; Giardia; Humans; Male; Mexico; Organometallic Compounds; Salicylates; Shigella; Specimen Handling; Travel | 1988 |
[Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
Topics: Adult; Aged; Bismuth; Campylobacter; Campylobacter Infections; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Organometallic Compounds; Random Allocation; Recurrence; Salicylates; Stomach Ulcer; Wound Healing | 1988 |
Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.
Topics: Adult; Aged; Bismuth; Campylobacter; Campylobacter Infections; Clinical Trials as Topic; Erythromycin; Erythromycin Ethylsuccinate; Female; Gastric Mucosa; Gastritis; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Salicylates; Salicylic Acid | 1986 |
Bismuth subsalicylate in the treatment and prevention of diarrheal disease.
Topics: Adolescent; Adult; Bismuth; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Humans; Middle Aged; Organometallic Compounds; Salicylates | 1987 |
Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Patient Compliance; Salicylates; Salmonella enteritidis; Shigella dysenteriae; Tablets; Travel | 1986 |
Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate.
Topics: Adult; Bismuth; Diarrhea; Humans; Mexico; Organometallic Compounds; Probability; Random Allocation; Salicylates; Tablets; Travel | 1987 |
Nonfluid therapy and selected chemoprophylaxis of acute diarrhea.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bismuth; Campylobacter Infections; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Diarrhea, Infantile; Drug Combinations; Dysentery, Amebic; Dysentery, Bacillary; Escherichia coli Infections; Giardiasis; Humans; Infant; Kaolin; Loperamide; Narcotics; Organometallic Compounds; Parasympatholytics; Pectins; Salicylates; Salmonella Infections; Travel | 1985 |
Bismuth subsalicylate in the treatment of chronic diarrhea of childhood.
Topics: Bismuth; Body Weight; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Defecation; Diarrhea, Infantile; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infant; Male; Organometallic Compounds; Prospective Studies; Random Allocation; Salicylates | 1985 |
Prevention of traveler's diarrhea.
Topics: Bismuth; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Enterotoxins; Escherichia coli; Escherichia coli Infections; Humans; Organometallic Compounds; Salicylates; Travel | 1985 |
Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea.
Topics: Acute Disease; Adult; Antidiarrheals; Bismuth; Diarrhea; Humans; Latin America; Loperamide; Organometallic Compounds; Piperidines; Salicylates; Travel; United States | 1986 |
Travellers' diarrhoea: prevention by chemoprophylaxis.
Topics: Adult; Bismuth; Clioquinol; Diarrhea; Drug Combinations; Drug Therapy, Combination; Furazolidone; Humans; Neomycin; Organometallic Compounds; Salicylates; Streptomycin; Sulfadiazine; Sulfamethazine; Sulfathiazoles; Travel | 1983 |
Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
Topics: Antidiarrheals; Bismuth; Diarrhea; Double-Blind Method; Escherichia coli Infections; Feces; Female; Humans; Male; Organometallic Compounds; Random Allocation; Salicylates; Travel | 1983 |
Evaluation of bismuth subsalicylate in relieving symptoms of indigestion.
Topics: Adolescent; Adult; Bismuth; Clinical Trials as Topic; Digestion; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates | 1984 |
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth).
Topics: Adult; Bismuth; Clinical Trials as Topic; Diarrhea; Escherichia coli Infections; Humans; Mexico; Organometallic Compounds; Salicylates; Travel; United States | 1980 |
Influence of subsalicylate bismuth on absorption of doxycycline.
Topics: Adult; Biological Availability; Bismuth; Clinical Trials as Topic; Double-Blind Method; Doxycycline; Drug Interactions; Humans; Male; Organometallic Compounds; Random Allocation; Salicylates; Vomiting | 1982 |
Bismuth subsalicylate therapy of viral gastroenteritis.
Topics: Adolescent; Adult; Antibodies, Viral; Bismuth; Double-Blind Method; Female; Gastroenteritis; Gastrointestinal Agents; Humans; Male; Organometallic Compounds; Parvoviridae; Random Allocation; Salicylates; Virus Diseases | 1980 |
The role of location of food consumption in the prevention of travelers' diarrhea in Mexico.
Topics: Bismuth; Diarrhea; Food Contamination; Food Microbiology; Humans; Mexico; Organometallic Compounds; Placebos; Restaurants; Salicylates; Travel; United States | 1980 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1995 |
Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients.
Topics: Adult; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Salicylates; Time Factors | 1995 |
Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
Topics: Absorption; Administration, Oral; Adult; Biological Availability; Bismuth; Ciprofloxacin; Cross-Over Studies; Drug Interactions; Female; Humans; Male; Organometallic Compounds; Salicylates | 1994 |
Earth, wind, and fiber: is there a drug to treat acute diarrhea?
Topics: Bismuth; Diarrhea, Infantile; Dietary Fiber; Egypt; Gastrointestinal Agents; Humans; Infant; Male; Organometallic Compounds; Salicylates; Silicates | 1994 |
Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
Topics: Azithromycin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Topics: Adult; Aged; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline | 1993 |
Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.
Topics: Adult; Bismuth; Chronic Disease; Double-Blind Method; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Leukocyte Count; Organometallic Compounds; Salicylates; Treatment Outcome | 1993 |
Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline | 1993 |
Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Stomach Ulcer; Tetracycline | 1993 |
A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease.
Topics: Acute Disease; Bismuth; Body Weight; Chemotherapy, Adjuvant; Child, Preschool; Diarrhea, Infantile; Double-Blind Method; Fluid Therapy; Humans; Infant; Male; Multivariate Analysis; Organometallic Compounds; Salicylates | 1993 |
Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Penicillins; Recurrence; Salicylates | 1995 |
Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Bismuth; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastric Mucosa; Horse Diseases; Horses; Hydrogen-Ion Concentration; Magnesium Hydroxide; Male; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Salicylates; Stomach | 1996 |
Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Chile; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Salicylates; Single-Blind Method; Time Factors | 1996 |
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Salicylates; Stomach Ulcer; Time Factors; Tinidazole | 1996 |
One-week therapy for Helicobacter pylori. A randomized trial of two treatment regimens.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1996 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Dyspepsia; Evaluation Studies as Topic; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Taste Disorders | 1997 |
Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Smoking; Tetracycline; Tetracyclines | 1997 |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Salicylates; Tetracycline; Urea | 1997 |
Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peru; Recurrence; Salicylates; Tetracycline; Tinidazole | 1997 |
Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
Topics: Adolescent; Adult; Aluminum Compounds; Antacids; Biological Availability; Bismuth; Chromatography, High Pressure Liquid; Cross-Over Studies; Female; Humans; Intestinal Absorption; Magnesium Compounds; Male; Middle Aged; Organometallic Compounds; Regression Analysis; Salicylates; Silicates; Tetracycline | 1997 |
Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis.
Topics: Administration, Oral; Adult; Aged; Bismuth; Colitis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates; Treatment Outcome | 1998 |
Bismuth binds...
Topics: Bismuth; Colitis; Humans; Organometallic Compounds; Salicylates | 1999 |
Evaluation of effects of ethyl alcohol and bismuth subsalicylate on gastric mucosal barrier in man.
Topics: Adult; Bismuth; Ethanol; Female; Gastric Acid; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Organometallic Compounds; Salicylates | 1999 |
Garlic or jalapeño peppers for treatment of Helicobacter pylori infection.
Topics: Adult; Bismuth; Capsicum; Cross-Over Studies; Female; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Phytotherapy; Plants, Medicinal; Prospective Studies; Salicylates | 1999 |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Salicylates; Treatment Outcome | 1999 |
A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Health Maintenance Organizations; Helicobacter Infections; Helicobacter pylori; Humans; Male; Massachusetts; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Program Evaluation; Salicylates; Tetracycline; Treatment Outcome | 1999 |
Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Outlet Obstruction; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study.
Topics: Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Prospective Studies; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome; Urea | 2001 |
Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Calcium Carbonate; Drug Therapy, Combination; Epithelium; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Metronidazole; Middle Aged; Organometallic Compounds; Penicillins; Placebos; Risk Factors; Salicylates; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2001 |
Which place for bismuth subsalicylate in the treatment of enteric infections?
Topics: Acute Disease; Bismuth; Child, Preschool; Diarrhea; Gastroenteritis; Humans; Infant; Organometallic Compounds; Rehydration Solutions; Salicylates | 2001 |
The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea.
Topics: Acute Disease; Bismuth; Child, Preschool; Diarrhea; Double-Blind Method; Escherichia coli Infections; Humans; Infant; Organometallic Compounds; Rehydration Solutions; Retroviridae Infections; Salicylates | 2001 |
In vitro longitudinal assessment of coronal discoloration from endodontic sealers.
Topics: Bicuspid; Bismuth; Calcium Hydroxide; Dental Pulp Cavity; Drug Combinations; Epoxy Resins; Follow-Up Studies; Humans; Humidity; Image Processing, Computer-Assisted; Longitudinal Studies; Methenamine; Root Canal Filling Materials; Salicylates; Silver; Single-Blind Method; Temperature; Titanium; Tooth Crown; Tooth Discoloration; Zinc Oxide-Eugenol Cement | 2001 |
Effect of three root canal sealers on the retentive strength of endodontic posts luted with a resin cement.
Topics: Analysis of Variance; Bismuth; Calcium Hydroxide; Dental Bonding; Dental Prosthesis Retention; Dental Stress Analysis; Dentin-Bonding Agents; Drug Combinations; Epoxy Resins; Gutta-Percha; Humans; Humidity; Materials Testing; Phosphates; Post and Core Technique; Resin Cements; Root Canal Filling Materials; Root Canal Preparation; Salicylates; Silver; Statistics as Topic; Stress, Mechanical; Surface Properties; Time Factors; Titanium; Zinc Oxide-Eugenol Cement | 2002 |
Apical leakage of four endodontic sealers.
Topics: Adhesiveness; Analysis of Variance; Bismuth; Calcium Hydroxide; Dental Bonding; Dental Leakage; Drug Combinations; Epoxy Resins; Filtration; Glass Ionomer Cements; Humans; Humidity; Root Canal Filling Materials; Root Canal Preparation; Salicylates; Silver; Statistics as Topic; Temperature; Time Factors; Titanium; Tooth Apex; Zinc Oxide-Eugenol Cement | 2003 |
Effect of Er:YAG laser and EDTAC on the adhesiveness to dentine of different sealers containing calcium hydroxide.
Topics: Adhesiveness; Aluminum Silicates; Analysis of Variance; Bismuth; Calcium Hydroxide; Chelating Agents; Dental Bonding; Dentin; Edetic Acid; Erbium; Humans; Lasers; Materials Testing; Root Canal Filling Materials; Salicylates; Stress, Mechanical; Surface Properties; Yttrium; Zinc Oxide | 2003 |
Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment.
Topics: Adult; Amoxicillin; Antacids; Bismuth; Calcium Carbonate; Drug Therapy, Combination; Dyspepsia; Female; Gastric Acidity Determination; Gastritis, Atrophic; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Salicylates; Tetracycline | 2003 |
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Severity of Illness Index; Treatment Outcome | 2003 |
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Prospective Studies; Proton-Translocating ATPases; Rabeprazole; Salicylates; Tetracycline; Treatment Outcome | 2004 |
Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C urea breath test.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Breath Tests; Carbon Isotopes; Citric Acid; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Salicylates; Sensitivity and Specificity; Treatment Outcome; Urea | 2005 |
Depth and percentage of penetration of endodontic sealers into dentinal tubules after root canal obturation using a lateral compaction technique: a confocal laser scanning microscopy study.
Topics: Bismuth; Calcium Hydroxide; Dental Marginal Adaptation; Dental Pulp Cavity; Dentin; Dimethylpolysiloxanes; Drug Combinations; Fluorescent Dyes; Gutta-Percha; Humans; Materials Testing; Microscopy, Confocal; Rhodamines; Root Canal Filling Materials; Root Canal Irrigants; Root Canal Obturation; Root Canal Preparation; Salicylates; Smear Layer; Surface Properties; Tooth Apex | 2009 |
Reliability of assessing dye penetration along root canal fillings using methylene blue.
Topics: Bismuth; Calcium Hydroxide; Coloring Agents; Composite Resins; Dental Bonding; Dental Leakage; Epoxy Resins; Fluorescent Dyes; Gutta-Percha; Humans; Materials Testing; Methylene Blue; Reproducibility of Results; Rhodamines; Root Canal Filling Materials; Root Canal Preparation; Salicylates; Surface Properties; Time Factors | 2009 |
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antidiarrheals; Bismuth; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline; Young Adult | 2012 |
Design, evaluation, and dissemination of a plastic syringe clip to improve dosing accuracy of liquid medications.
Topics: Administration, Oral; Adult; Antidiarrheals; Bismuth; Equipment Design; Female; Humans; Male; Organometallic Compounds; Salicylates; Syringes | 2013 |
Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Probiotics; Prognosis; Prospective Studies; Salicylates; Thailand | 2014 |
High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand.
Topics: Anti-Bacterial Agents; Antidiarrheals; Bismuth; Breath Tests; Clarithromycin; Cytochrome P-450 CYP2C19; Dexlansoprazole; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Thailand | 2015 |
Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Bismuth; Breath Tests; Clinical Protocols; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Salicylates; Turkey | 2015 |
Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Bismuth; Cholera; Diarrhea; Disease Outbreaks; Emergency Medical Services; Feces; Female; Fluid Therapy; Haiti; Humans; Length of Stay; Male; Organometallic Compounds; Probiotics; Saccharomyces; Salicylates; Severity of Illness Index; Treatment Outcome; Vibrio cholerae | 2015 |
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline; Young Adult | 2017 |
A Prospective, randomized study comparing 7-day and 14-day quadruple therapies as first-line treatments for helicobacter pylori infection in patients with functional dyspepsia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates | 2018 |
Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study.
Topics: Adolescent; Adult; Antidiarrheals; Bismuth; Delayed-Action Preparations; Diarrhea; Dimethyl Fumarate; Double-Blind Method; Drug Therapy, Combination; Female; Flatulence; Healthy Volunteers; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Organometallic Compounds; Salicylates; Young Adult | 2018 |
Effect of Bismuth Subsalicylate vs Placebo on Use of Antibiotics Among Adult Outpatients With Diarrhea in Pakistan: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antidiarrheals; Antimicrobial Stewardship; Bismuth; Diarrhea; Drug Utilization; Female; Follow-Up Studies; Humans; Inappropriate Prescribing; Logistic Models; Male; Middle Aged; Organometallic Compounds; Pakistan; Practice Patterns, Physicians'; Salicylates; Young Adult | 2019 |
Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Doxycycline; Drug Therapy, Combination; Esomeprazole; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Salicylates; Syria; Tinidazole; Treatment Outcome; Young Adult | 2021 |
Effects of bismuth subsalicylate and encapsulated calcium-ammonium nitrate on feedlot beef cattle production.
Topics: Animal Feed; Animals; Bismuth; Calcium; Cattle; Diet; Digestion; Nitrates; Organometallic Compounds; Rumen; Salicylates | 2021 |
315 other study(ies) available for bismuth and salicylates
| Article | Year |
|---|---|
Prevention by bismuth subsalicylate of gastric mucosal lesions in response to noxious stimuli in rats.
Topics: Animals; Aspirin; Bismuth; Cold Temperature; Condiments; Ethanol; Female; Gastrointestinal Hemorrhage; Male; Rats; Restraint, Physical; Salicylates; Time Factors | 1978 |
Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae.
Topics: Animals; Bacterial Toxins; Bismuth; Cells, Cultured; Cholera Toxin; Enterotoxins; Escherichia coli; Ileum; Intestinal Mucosa; Organometallic Compounds; Rabbits; Salicylates; Water | 1977 |
The effect of adsorbant and anti-inflammatory drugs on secretion in ligated segments of pig intestine infected with Escherichia coli.
Topics: Animals; Anti-Inflammatory Agents; Antidiarrheals; Aspirin; Bismuth; Enterotoxins; Escherichia coli; Escherichia coli Infections; Intestinal Secretions; Jejunum; Kaolin; Ligation; Lincomycin; Methylprednisolone; Organometallic Compounds; Pectins; Polymyxin B; Salicylates; Swine; Swine Diseases | 1978 |
Decreased tetracycline bioavailability caused by a bismuth subsalicylate antidiarrheal mixture.
Topics: Adult; Antidiarrheals; Biological Availability; Bismuth; Drug Interactions; Humans; Intestinal Absorption; Salicylates; Tetracycline | 1979 |
[Microbial contamination of some non-injection drug preparations].
Topics: Anti-Infective Agents, Local; Bismuth; Dosage Forms; Drug Contamination; Drug Industry; Drug Storage; Emollients; Emulsions; Humans; Ointment Bases; Ointments; Pharmaceutic Aids; Phenols; Salicylates; Salmonella Infections; Sepsis; Sterilization; Tablets; Technology, Pharmaceutical; Temperature; Time Factors; Water Microbiology | 1976 |
Use of an ammonia electrode for rapid quantification of Helicobacter pylori urease: its use in the endoscopy room and in the assessment of urease inhibition by bismuth subsalicylate.
Topics: Ammonia; Bismuth; Electrodes; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; In Vitro Techniques; Male; Middle Aged; Organometallic Compounds; Salicylates; Sensitivity and Specificity; Urease | 1992 |
Apical dye penetration with four root canal sealers and gutta-percha using longitudinal sectioning.
Topics: Analysis of Variance; Bismuth; Calcium Hydroxide; Dental Leakage; Drug Combinations; Epoxy Resins; Gutta-Percha; Humans; Methenamine; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Silver; Titanium; Zinc Oxide-Eugenol Cement | 1992 |
Effects of salicylate and other enhancers on rectal absorption of erythropoietin in rats.
Topics: Administration, Rectal; Animals; Biological Availability; Bismuth; Erythropoietin; Intestinal Absorption; Magnesium; Male; Rats; Rats, Inbred Strains; Rectum; Salicylates; Salicylic Acid; Stimulation, Chemical | 1992 |
Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bismuth; Drug Interactions; Microbial Sensitivity Tests; Organometallic Compounds; Pseudomonas aeruginosa; Salicylates; Salicylic Acid; Sodium Salicylate | 1992 |
Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence.
Topics: Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Ranitidine; Recurrence; Salicylates; Tetracycline | 1992 |
Effect of different sealers on thermoplasticized Gutta-percha root canal obturations.
Topics: Analysis of Variance; Bismuth; Calcium Hydroxide; Dental Cements; Dental Leakage; Drug Combinations; Epoxy Resins; Glass Ionomer Cements; Gutta-Percha; Magnesium Oxide; Materials Testing; Methenamine; Polycarboxylate Cement; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Silver; Titanium; Zinc Oxide; Zinc Oxide-Eugenol Cement | 1992 |
Pepto-Bismol mimicking pancreatic calcification.
Topics: Abdomen; Administration, Oral; Adult; Bismuth; Calcinosis; Diagnosis, Differential; Foreign Bodies; Humans; Male; Organometallic Compounds; Pancreatic Diseases; Radiography; Salicylates | 1992 |
Antimicrobial activity of seven root canal sealers. Results of agar diffusion and agar dilution tests.
Topics: Administration, Topical; Agar; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Bismuth; Calcium Hydroxide; Colony Count, Microbial; Dexamethasone; Drug Combinations; Epoxy Resins; Eugenol; Formaldehyde; Hydrocortisone; Methenamine; Microbial Sensitivity Tests; Polymers; Polyvinyls; Resorcinols; Root Canal Filling Materials; Salicylates; Silver; Staphylococcus aureus; Thymol; Titanium; Zinc Oxide; Zinc Oxide-Eugenol Cement | 1992 |
Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria.
Topics: Bacteria; Bismuth; Colony Count, Microbial; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Organometallic Compounds; Salicylates; Tumor Cells, Cultured | 1992 |
Deposition of bismuth by Yersinia enterocolitica.
Topics: Bismuth; Crystallization; Electron Probe Microanalysis; Microscopy, Electron, Scanning; Organometallic Compounds; Salicylates; Yersinia enterocolitica | 1992 |
Comparative tissue tolerance of a new endodontic sealer.
Topics: Animals; Biocompatible Materials; Bismuth; Bisphenol A-Glycidyl Methacrylate; Calcium Hydroxide; Connective Tissue; Contrast Media; Dental Bonding; Dental Cements; Drug Combinations; Epoxy Resins; Giant Cells; Granulation Tissue; Macrophages; Materials Testing; Methenamine; Neutrophils; Polymethacrylic Acids; Rats; Rats, Inbred Strains; Resins, Synthetic; Root Canal Filling Materials; Salicylates; Silver; Skin; Time Factors; Titanium | 1992 |
Comparison of one-day oral dosing with three bismuth compounds for the suppression of Helicobacter pylori assessed by the 13C-urea breath test.
Topics: Adult; Aged; Analysis of Variance; Bismuth; Breath Tests; Carbon Dioxide; Female; Gastric Mucosa; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates; Urea; Urease | 1992 |
Transmucosal penetration of bismuth particles in the human stomach.
Topics: Adult; Aged; Bismuth; Digestive System; Electron Probe Microanalysis; Endoscopy; Female; Gastric Mucosa; Humans; Male; Microscopy, Electron; Middle Aged; Organometallic Compounds; Salicylates; Salicylic Acid | 1992 |
Factors influencing the eradication of Helicobacter pylori with triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Regression Analysis; Salicylates; Stomach Ulcer; Tetracycline | 1992 |
A comparative study of the apical leakage of four root canal sealers and laterally condensed gutta-percha.
Topics: Bismuth; Calcium Hydroxide; Coloring Agents; Dental Leakage; Drug Combinations; Epoxy Resins; Humans; Materials Testing; Methenamine; Root Canal Filling Materials; Salicylates; Silver; Titanium; Zinc Oxide-Eugenol Cement | 1991 |
Fatal salicylate toxicity from bismuth subsalicylate.
Topics: Aged; Aged, 80 and over; Bismuth; Female; Humans; Organometallic Compounds; Salicylates | 1991 |
Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Capsules; Bismuth; Drug Synergism; Gram-Negative Bacteria; Klebsiella pneumoniae; Nitrates; Organometallic Compounds; Polysaccharides, Bacterial; Salicylates; Sodium Salicylate | 1991 |
Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuth subsalicylate and nitrofurantoin.
Topics: Adult; Bismuth; Breath Tests; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitrofurantoin; Organometallic Compounds; Salicylates; Urea | 1991 |
Adhesion of sealer cements to dentin with and without the smear layer.
Topics: Adhesiveness; Analysis of Variance; Bismuth; Calcium Hydroxide; Dental Cements; Dental Leakage; Dentin; Drug Combinations; Epoxy Resins; Eugenol; Humans; Materials Testing; Methenamine; Root Canal Filling Materials; Salicylates; Silver; Tensile Strength; Titanium; Zinc Oxide; Zinc Oxide-Eugenol Cement | 1991 |
Epidemiology and treatment of gastric Campylobacter pylori infection: more questions than answers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Diagnosis, Differential; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Prevalence; Salicylates; Tinidazole; Urease | 1990 |
Long-term follow-up of voluntary ingestion of Helicobacter pylori.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Organometallic Compounds; Recurrence; Salicylates | 1991 |
Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Dinoprostone; Duodenitis; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates | 1991 |
Helicobacter pylori.
Topics: Bismuth; Child; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Salicylates | 1991 |
Insoluble bismuth (subsalicylate) should be revived for treatment of LE in general and SCLE in particular.
Topics: Bismuth; Humans; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Organometallic Compounds; Salicylates; Syphilis | 1991 |
For your information: traveler's diarrhea.
Topics: Bismuth; Diarrhea; Fluid Therapy; Food Microbiology; Humans; Organometallic Compounds; Risk Factors; Salicylates; Travel; Water Microbiology; Water Supply | 1991 |
Rectal bismuth subsalicylate as therapy for ulcerative colitis.
Topics: Administration, Rectal; Adolescent; Adult; Bismuth; Colitis, Ulcerative; Colon; Female; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates | 1990 |
The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate).
Topics: Adult; Bismuth; Female; Humans; Male; Organometallic Compounds; Salicylates; Salicylic Acid | 1990 |
Bismuth subsalicylate reduces peptic injury of the oesophagus in rabbits.
Topics: Animals; Bismuth; Disease Models, Animal; Dose-Response Relationship, Drug; Esophagitis; Esophagus; Mucous Membrane; Organometallic Compounds; Pepsin A; Rabbits; Salicylates | 1990 |
In vitro comparison of the cytotoxicity of twelve endodontic materials using a new technique.
Topics: Administration, Topical; Anti-Inflammatory Agents; Balsams; Biocompatible Materials; Bismuth; Bisphenol A-Glycidyl Methacrylate; Calcium Hydroxide; Cells, Cultured; Dental Cements; Dentin; Dexamethasone; Drug Combinations; Epoxy Resins; Formaldehyde; Gutta-Percha; Hydrocortisone; Methacrylates; Methenamine; Polymers; Polyvinyls; Resorcinols; Root Canal Filling Materials; Salicylates; Silver; Thymol; Titanium; Zinc Oxide; Zinc Oxide-Eugenol Cement | 1990 |
Hyperplastic gastric polyps associated with persistent Helicobacter pylori infection and active gastritis.
Topics: Aged; Amoxicillin; Bismuth; Campylobacter Infections; Chronic Disease; Female; Gastritis; Helicobacter pylori; Humans; Hyperplasia; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Polyps; Salicylates; Stomach; Stomach Neoplasms | 1990 |
Emporiatrics: diarrhea in travelers.
Topics: Bismuth; Campylobacter jejuni; Diarrhea; Dysentery, Bacillary; Food Contamination; Giardiasis; Humans; Organometallic Compounds; Rotavirus Infections; Salicylates; Salmonella Infections; Sulfonamides; Travel | 1990 |
Systemic chemotherapy for Helicobacter pylori eradication?
Topics: Administration, Oral; Bismuth; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Salicylates | 1990 |
Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy.
Topics: Acquired Immunodeficiency Syndrome; Antidiarrheals; Bismuth; Brain Diseases; Diarrhea; Humans; Intestinal Absorption; Male; Middle Aged; Myoclonus; Organometallic Compounds; Salicylates | 1990 |
Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection.
Topics: Bismuth; Campylobacter Infections; Drug Therapy, Combination; Duodenal Ulcer; Female; Food; Gastrins; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline | 1990 |
Bismuth.
Topics: Bismuth; Humans; Organometallic Compounds; Salicylates; Stomatitis; Tooth Discoloration | 1990 |
Bismuth subsalicylate in the prevention of colonization of infant mice with Campylobacter jejuni.
Topics: Animals; Animals, Newborn; Bismuth; Campylobacter fetus; Campylobacter Infections; Colony Count, Microbial; Diarrhea; Dose-Response Relationship, Drug; Female; Intestines; Male; Mice; Microbial Sensitivity Tests; Organometallic Compounds; Salicylates | 1990 |
[Pharmacokinetics of bismuth preparations in patients with gastritis and ulcer disease].
Topics: Administration, Oral; Bismuth; Campylobacter Infections; Dose-Response Relationship, Drug; Gastritis; Humans; Organometallic Compounds; Salicylates; Stomach Ulcer | 1990 |
Treatment of Campylobacter pylori does not alter gastric acid secretion.
Topics: Amoxicillin; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Gastric Acid; Gastritis; Humans; Organometallic Compounds; Salicylates | 1989 |
Histopathologic findings and energy dispersive X-ray spectroscopic analysis of experimentally induced foreign-body pneumonias in rats.
Topics: Animals; Barium Sulfate; Bismuth; Drug Combinations; Electron Probe Microanalysis; Female; Kaolin; Lung; Mineral Oil; Organometallic Compounds; Pectins; Pneumonia, Aspiration; Rats; Rats, Inbred Strains; Salicylates | 1989 |
Treatment of Campylobacter gastritis in young children.
Topics: Adolescent; Amoxicillin; Bismuth; Campylobacter Infections; Child; Child, Preschool; Chronic Disease; Gastritis; Humans; Infant; Organometallic Compounds; Salicylates | 1989 |
Can bismuth decrease the kidney toxic effect of cis-platinum?
Topics: Bismuth; Cisplatin; Female; Humans; Kidney Diseases; Organometallic Compounds; Ovarian Neoplasms; Salicylates | 1989 |
The effect of human blood on the sealing ability of root canal sealers: an in vitro study.
Topics: Administration, Topical; Anti-Inflammatory Agents; Bismuth; Blood; Dental Bonding; Dental Cements; Dental Leakage; Dexamethasone; Drug Combinations; Epoxy Resins; Fatty Acids; Formaldehyde; Gutta-Percha; Humans; Hydrocortisone; Methenamine; Methylene Blue; Polyvinyls; Resins, Plant; Root Canal Filling Materials; Salicylates; Silver; Thymol; Titanium; Water; Zinc Oxide; Zinc Oxide-Eugenol Cement | 1989 |
[Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
Topics: Anti-Ulcer Agents; Bismuth; Cimetidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Humans; Male; Middle Aged; Organometallic Compounds; Ranitidine; Recurrence; Salicylates | 1989 |
Binding and killing of bacteria by bismuth subsalicylate.
Topics: Adenosine Triphosphate; Bacteria; Bismuth; Campylobacter; Culture Media; Escherichia coli; Gastric Juice; Hydrogen-Ion Concentration; Organometallic Compounds; Protein Binding; Salicylates; Salmonella typhimurium; Serum Albumin; Staphylococcus aureus | 1989 |
Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s).
Topics: Adolescent; Adult; Aged; Bismuth; Campylobacter; Duodenitis; Dyspepsia; Endoscopy; Gastric Mucosa; Gastritis; Humans; Metronidazole; Middle Aged; Organometallic Compounds; Pyloric Antrum; Salicylates | 1989 |
Clinical experience with Campylobacter pylori in western Kentucky.
Topics: Amoxicillin; Bismuth; Campylobacter Infections; Humans; Organometallic Compounds; Salicylates | 1989 |
The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Campylobacter; Gallic Acid; Humans; Molecular Structure; Organometallic Compounds; Salicylates | 1989 |
Pepto-bismol and salicylate levels.
Topics: Bismuth; Humans; Organometallic Compounds; Salicylates; Salicylic Acid | 1989 |
Hidden salicylates.
Topics: Bismuth; Child; Humans; Nonprescription Drugs; Organometallic Compounds; Reye Syndrome; Salicylates | 1989 |
In vivo susceptibility of Campylobacter pylori.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Breath Tests; Campylobacter; Campylobacter Infections; Duodenum; Humans; Organometallic Compounds; Salicylates; Stomach | 1989 |
[Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
Topics: Amoxicillin; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates | 1989 |
[How do I treat seborrheic eczema?].
Topics: Administration, Topical; Anti-Inflammatory Agents; Bismuth; Dermatitis, Seborrheic; Glucocorticoids; Humans; Ointments; Salicylates; Sulfur; Zinc | 1986 |
In vitro activities of bismuth salts against rotaviruses and other enteric viruses.
Topics: Animals; Bismuth; Cattle; Cells, Cultured; Enterovirus; Humans; Organometallic Compounds; Rotavirus; Salicylates; Tartrates; Viral Plaque Assay | 1985 |
Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease.
Topics: Adult; Biopsy; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Humans; Male; Middle Aged; Nitrofurantoin; Organometallic Compounds; Pilot Projects; Pyloric Antrum; Salicylates; Stomach Ulcer; Urease | 1988 |
Chronic erosive gastritis--a therapeutic approach with bismuth.
Topics: Adult; Bismuth; Campylobacter; Chronic Disease; Female; Gastritis; Gastroscopy; Humans; Male; Middle Aged; Organometallic Compounds; Pyloric Antrum; Salicylates; Stomach | 1988 |
Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
Topics: Adolescent; Ampicillin; Bismuth; Campylobacter; Campylobacter Infections; Child; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Humans; Organometallic Compounds; Pyloric Antrum; Salicylates | 1988 |
Stress ulcer prophylaxis and ventilation pneumonia: prevention by antibacterial cytoprotective agents?
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Gastric Juice; Humans; Hydrogen-Ion Concentration; Organometallic Compounds; Peptic Ulcer; Pneumonia; Prospective Studies; Respiration, Artificial; Risk Factors; Salicylates; Stress, Physiological; Sucralfate; Trachea | 1988 |
[Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
Topics: Adult; Aged; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Chronic Disease; Drug Evaluation; Female; Gastric Mucosa; Gastritis; Gastroscopy; Humans; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Middle Aged; Organometallic Compounds; Salicylates | 1988 |
[Cytotoxicity of root canal filling materials. 2. Preparation of calcium hydroxide (Calvital), paraformaldehyde (Triozinc paste), epoxy resin (AH 26), guaiacol formaldehyde resin (FR), and other root canal filling materials (N2, Nogenol)].
Topics: Bismuth; Calcium Hydroxide; Cells, Cultured; Drug Combinations; Epoxy Resins; Eugenol; Fatty Acids; Formaldehyde; Guaiacol; L Cells; Methenamine; Resins, Plant; Root Canal Filling Materials; Salicylates; Silver; Thymol; Titanium; Zinc Oxide | 1986 |
The treatment of Campylobacter-associated gastritis.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Erythromycin; Erythromycin Ethylsuccinate; Gastritis; Humans; Organometallic Compounds; Salicylates | 1987 |
Therapy for collagenous colitis.
Topics: Adult; Antidiarrheals; Bismuth; Colitis; Humans; Male; Organometallic Compounds; Salicylates | 1987 |
In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.
Topics: Anti-Bacterial Agents; Bismuth; Campylobacter; Cimetidine; Humans; Microbial Sensitivity Tests; Organometallic Compounds; Salicylates; Sucralfate | 1987 |
Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid.
Topics: Bacteria; Bismuth; Gastric Juice; Humans; Organometallic Compounds; Salicylates; Sucralfate | 1987 |
[Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Topics: Anti-Ulcer Agents; Bismuth; Campylobacter Infections; Chronic Disease; Duodenal Ulcer; Gastritis; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates; Stomach Ulcer | 1987 |
Dangers from hidden salicylates.
Topics: Adolescent; Bismuth; Child; Humans; Organometallic Compounds; Reye Syndrome; Salicylates | 1986 |
Pepto-Bismal efficacy studies for diarrhea. indication submitted to FDA.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates | 1986 |
[In vitro effect of 2 pharmaceutical preparations containing bismuth on the fermentative capacity of intestinal bacteria].
Topics: Antacids; Bacteria; Bismuth; Feces; Fermentation; Humans; In Vitro Techniques; Intestines; Lactose; Organometallic Compounds; Salicylates | 1985 |
Travelers' diarrhea. Controversy and consensus.
Topics: Antidiarrheals; Bismuth; Diarrhea; Doxycycline; Drug Combinations; Food; Humans; Organometallic Compounds; Risk; Salicylates; Sulfamethoxazole; Terminology as Topic; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vaccination | 1985 |
Determination of bismuth in pharmaceutical dosage forms by conventional DC polarography.
Topics: Aluminum; Arsenic; Ascorbic Acid; Bismuth; Colorimetry; Drug Combinations; Emulsions; Evaluation Studies as Topic; Glycols; Methods; Nitrates; Oxides; Polarography; Powders; Salicylates; Sodium; Suspensions; Tablets | 1972 |
Uropepsin excretion and the effect of antacid materials.
Topics: Adult; Bicarbonates; Biological Assay; Bismuth; Carbonates; Endopeptidases; Humans; Hydroxides; Magnesium; Salicylates | 1967 |
Bedside toxicology.
Topics: Alcohols; Antimony; Arsenic Poisoning; Barbiturates; Bismuth; Bromides; Carbon Monoxide Poisoning; Child; Coloring Agents; Humans; Indicators and Reagents; Iron; Kerosene; Lead Poisoning; Mercury Poisoning; Methods; Parathion; Phenothiazines; Poisoning; Quinidine; Quinine; Salicylates; Strychnine; Sulfanilamides | 1970 |
[On the dispersion of suspended solid materials by ultrasound].
Topics: Acetates; Aluminum Silicates; Bismuth; Calcium Carbonate; Carbonates; Chemical Phenomena; Chemistry, Physical; Densitometry; Microscopy; Oxides; Prednisolone; Prednisone; Salicylates; Solvents; Sulfathiazoles; Sulfides; Sulfur; Surface-Active Agents; Suspensions; Talc; Time Factors; Titanium; Ultrasonics; Viscosity; Zinc | 1969 |
Traveler's diarrhea: update 1983.
Topics: Bismuth; Child; Diarrhea; Doxycycline; Drug Combinations; Escherichia coli Infections; Humans; Organometallic Compounds; Premedication; Salicylates; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Prevention and treatment of "traveler's diarrhea".
Topics: Bismuth; Diarrhea; Doxycycline; Drug Combinations; Escherichia coli Infections; Humans; Organometallic Compounds; Salicylates; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
In vitro bile acid adsorption by bismuth subsalicylate and montmorillonite.
Topics: Adsorption; Bentonite; Bile Acids and Salts; Bismuth; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; In Vitro Techniques; Organometallic Compounds; Salicylates; Solutions | 1984 |
Traveler's diarrhea.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1983 |
Traveler's diarrhea in the Mediterranean basin.
Topics: Acute Disease; Adult; Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1980 |
Risk of hypercalcemia from prophylaxis of traveler's diarrhea.
Topics: Bismuth; Diarrhea; Humans; Hypercalcemia; Organometallic Compounds; Risk; Salicylates; Travel | 1983 |
Travelers' diarrhea.
Topics: Adult; Bismuth; Child; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1983 |
The physical properties of four endodontic sealer cements.
Topics: Bismuth; Chemical Phenomena; Chemistry, Physical; Dental Cements; Drug Combinations; Eugenol; Fatty Acids; Polyvinyls; Resins, Plant; Root Canal Filling Materials; Salicylates; Thymol; Zinc Oxide | 1982 |
[Clinico-pathological studies of the influence of root canal sealers on the exposed pulp wounds of human teeth (author's transl)].
Topics: Adolescent; Adult; Balsams; Bismuth; Dental Cavity Lining; Dental Pulp; Dental Pulp Exposure; Drug Combinations; Eugenol; Fatty Acids; Female; Gutta-Percha; Humans; Hydrocarbons, Iodinated; Male; Polyvinyls; Resins, Plant; Root Canal Filling Materials; Salicylates; Thymol; Zinc Oxide | 1982 |
Comparative evaluation of gastrointestinal blood loss in the feces of rats following Pepto-Bismol liquid and aspirin administration.
Topics: Animals; Aspirin; Bismuth; Feces; Gastrointestinal Hemorrhage; Male; Occult Blood; Organometallic Compounds; Rats; Salicylates | 1980 |
Black heme-positive stools without gastrointestinal hemorrhage.
Topics: Bismuth; Color; False Positive Reactions; Feces; Female; Gastrointestinal Hemorrhage; Heme; Humans; Infant; Organometallic Compounds; Salicylates | 1982 |
Traveler's diarrhea: must it spoil the patient's trip?
Topics: Bismuth; Diarrhea; Doxycycline; Drug Combinations; Humans; Organometallic Compounds; Salicylates; Sulfamethoxazole; Travel; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
How to avoid running with Escherichia coli.
Topics: Bismuth; Diarrhea; Escherichia coli Infections; Humans; Salicylates; Travel | 1980 |
[Experimental studies on the sealing properties of various kind of root canal sealers and pastes in vitro, with special reference to non-eugenol preparations (author's transl)].
Topics: Balsams; Barium Sulfate; Bismuth; Calcium Hydroxide; Dental Bonding; Drug Combinations; Epoxy Resins; Fatty Acids; Formaldehyde; Guaiacol; Gutta-Percha; Hydrogels; Methenamine; Ointments; Polyhydroxyethyl Methacrylate; Polyvinyls; Resins, Plant; Resins, Synthetic; Root Canal Filling Materials; Salicylates; Silicones; Silver; Thymol; Titanium; Zinc Oxide | 1980 |
Use of Pepto-Bismol in diarrhea.
Topics: Bismuth; Diarrhea; Drug Interactions; Humans; Salicylates | 1982 |
Travelers' diarrhea: recent advances in prophylaxis and treatment.
Topics: Bismuth; Diarrhea; Doxycycline; Fluid Therapy; Humans; Organometallic Compounds; Salicylates; Travel | 1982 |
Encephalopathy from bismuth subsalicylate.
Topics: Bismuth; Brain Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Salicylates | 1982 |
Salicylate absorption from a bismuth subsalicylate preparation.
Topics: Adult; Bismuth; Half-Life; Humans; Intestinal Absorption; Kinetics; Male; Organometallic Compounds; Salicylates | 1981 |
Absorption of salicylate and bismuth from a bismuth subsalicylate--containing compound (Pepto-Bismol).
Topics: Adult; Bismuth; Child; Humans; Intestinal Absorption; Male; Organometallic Compounds; Salicylates | 1981 |
Preventing traveler's diarrhea.
Topics: Bismuth; Diarrhea; Doxycycline; Humans; Organometallic Compounds; Salicylates; Travel | 1981 |
[Travellers' diarrhea].
Topics: Bismuth; Diarrhea; Humans; Salicylates; Travel | 1980 |
Salicylate in Pepto-Bismol.
Topics: Antidiarrheals; Bismuth; Drug Interactions; Humans; Nonprescription Drugs; Organometallic Compounds; Salicylates | 1980 |
Bismuth preparations for diarrhea.
Topics: Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 1980 |
Warning against products containing bismuth subsalicylate.
Topics: Bismuth; Gastrointestinal Diseases; Humans; Male; Organometallic Compounds; Salicylates | 1980 |
Effect of thickness on the sealing ability of some root canal sealers.
Topics: Air; Bismuth; Calcium Hydroxide; Dental Cements; Dental Leakage; Drug Combinations; Epoxy Resins; Glass Ionomer Cements; Gutta-Percha; Humans; Materials Testing; Methenamine; Root Canal Filling Materials; Salicylates; Silver; Surface Properties; Titanium; Zinc Oxide-Eugenol Cement | 1995 |
A comparison of three different root canal sealers when used to obturate a moisture-contaminated root canal system.
Topics: Analysis of Variance; Bismuth; Calcium Hydroxide; Dental Leakage; Drug Contamination; Drug Storage; Evaluation Studies as Topic; Glass Ionomer Cements; Gutta-Percha; Humans; Resins, Synthetic; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Water; Zinc Oxide | 1995 |
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Eczema responsive to treatment for Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Eczema; Gastroenteritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Recurrence; Salicylates; Tetracycline | 1995 |
Experimental study of the biocompatibility of four root canal sealers and their influence on the zinc and calcium content of several tissues.
Topics: Animals; Biocompatible Materials; Bismuth; Brain Chemistry; Calcium; Calcium Hydroxide; Connective Tissue; Drug Combinations; Epoxy Resins; Female; Foreign-Body Reaction; Kidney; Liver; Methenamine; Rats; Rats, Wistar; Root Canal Filling Materials; Salicylates; Silver; Tissue Distribution; Titanium; Uterus; Zinc; Zinc Oxide; Zinc Oxide-Eugenol Cement | 1995 |
Zinc as a growth factor for Aspergillus sp. and the antifungal effects of root canal sealants.
Topics: Acrylic Resins; Antifungal Agents; Aspergillosis; Aspergillus; Bismuth; Calcium Hydroxide; Drug Combinations; Epoxy Resins; Eugenol; Formaldehyde; Humans; Maxillary Sinusitis; Methenamine; Microbial Sensitivity Tests; Regression Analysis; Resin Cements; Root Canal Filling Materials; Salicylates; Silver; Spores, Fungal; Titanium; Zinc; Zinc Oxide; Zinc Oxide-Eugenol Cement | 1995 |
Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Antibodies, Bacterial; Bismuth; Child; Child, Preschool; Duodenal Ulcer; Endoscopy, Gastrointestinal; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Metronidazole; Organometallic Compounds; Polymerase Chain Reaction; Recurrence; Salicylates; Stomach Ulcer | 1995 |
Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment.
Topics: Adult; Aged; alpha-Glucosidases; Bismuth; Colitis, Ulcerative; Crohn Disease; Feces; Female; Humans; Longitudinal Studies; Male; Middle Aged; Organometallic Compounds; Salicylates; Sulfatases | 1995 |
Leakage of four root canal sealers at different thickness.
Topics: Animals; Bismuth; Calcium Hydroxide; Cattle; Chi-Square Distribution; Dental Leakage; Drug Combinations; Epoxy Resins; Glass Ionomer Cements; Methenamine; Rheology; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Silver; Time Factors; Titanium; Zinc Oxide-Eugenol Cement | 1994 |
Adhesion of calcium hydroxide-containing root canal sealers.
Topics: Acid Etching, Dental; Adhesiveness; Bismuth; Calcium Hydroxide; Dental Bonding; Dentin; Drug Combinations; Edetic Acid; Epoxy Resins; Humans; Materials Testing; Methenamine; Root Canal Filling Materials; Salicylates; Silver; Statistics, Nonparametric; Tensile Strength; Titanium; Zinc Oxide | 1994 |
Apical leakage using various sealers and root canal filling techniques.
Topics: Bismuth; Calcium Hydroxide; Dental Leakage; Drug Combinations; Epoxy Resins; Evaluation Studies as Topic; Humans; Incisor; Methenamine; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Silver; Titanium; Zinc Oxide-Eugenol Cement | 1994 |
The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
Topics: 16,16-Dimethylprostaglandin E2; Acrylic Resins; Animals; Bismuth; Duodenum; Gastric Mucosa; Intestinal Mucosa; Male; Mucus; Organometallic Compounds; Pepsin A; Peptic Ulcer; Rats; Rats, Wistar; Salicylates; Sucralfate | 1994 |
Effect of salicylate, bismuth, osmolytes, and tetracycline resistance on expression of fimbriae by Escherichia coli.
Topics: Bacterial Outer Membrane Proteins; Bismuth; Escherichia coli; Fimbriae, Bacterial; Hemagglutination Tests; Salicylates; Salicylic Acid; Sodium Chloride; Tetracycline Resistance | 1994 |
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Failure; Treatment Outcome | 1994 |
Bismuth toxicity.
Topics: Ataxia; Bismuth; Confusion; Delirium; Dyspepsia; Gait; Humans; Male; Memory Disorders; Middle Aged; Organometallic Compounds; Remission, Spontaneous; Salicylates; Tremor | 1994 |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline; Time Factors | 1994 |
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pepsinogens; Peptic Ulcer; Salicylates | 1994 |
Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
Topics: Acetaldehyde; Anti-Ulcer Agents; Bismuth; Catechols; Colloids; Depression, Chemical; Ethanol; Helicobacter pylori; Organometallic Compounds; Pentanones; Salicylates | 1994 |
Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Protein-Losing Enteropathies; Salicylates | 1994 |
H. pylori and ulcers.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates | 1994 |
Chronic salicylate toxicity due to consumption of over-the-counter bismuth subsalicylate.
Topics: Aged; Bismuth; Female; Humans; Organometallic Compounds; Radiography, Abdominal; Salicylates | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Salicylates; Stomach Ulcer | 1994 |
Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment.
Topics: Amoxicillin; Ascorbic Acid; Bismuth; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Organometallic Compounds; Salicylates; Smoking | 1994 |
Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol)
Topics: Aged; Bismuth; Electroencephalography; Female; Humans; Magnetic Resonance Imaging; Nervous System Diseases; Organometallic Compounds; Salicylates; Substance-Related Disorders | 1993 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Tetracycline | 1994 |
Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing.
Topics: Adult; Bismuth; Female; Food; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Peptic Ulcer; Protein Precursors; Protein Processing, Post-Translational; Salicylates; Tetracycline | 1993 |
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis.
Topics: Adult; Biopsy; Bismuth; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Organometallic Compounds; Pepsinogens; Salicylates | 1993 |
Bismuth in infants with watery diarrhea.
Topics: Bismuth; Child; Diarrhea, Infantile; Fluid Therapy; Humans; Infant; Organometallic Compounds; Salicylates | 1993 |
Bismuth in infants with watery diarrhea.
Topics: Bismuth; Child; Diarrhea, Infantile; Fluid Therapy; Humans; Infant; Organometallic Compounds; Salicylates | 1993 |
Aspirin and bismuth subsalicylate.
Topics: Aspirin; Bismuth; Child; Humans; Organometallic Compounds; Salicylates; Stomach Diseases | 1993 |
Treatment and long-term follow-up of Helicobacter pylori-associated duodenal ulcer disease in children.
Topics: Adolescent; Amoxicillin; Biopsy; Bismuth; Child; Child, Preschool; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Organometallic Compounds; Pyloric Antrum; Recurrence; Salicylates; Time Factors; Treatment Outcome | 1993 |
[Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Topics: Administration, Oral; Adult; Aged; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Salicylates; Tetracycline | 1993 |
Long-term Helicobacter pylori recurrence after successful eradication with triple therapy.
Topics: Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Recurrence; Salicylates; Tetracycline | 1993 |
Can bismuth improve the simple solution for diarrhea?
Topics: Bismuth; Diarrhea, Infantile; Fluid Therapy; Humans; Infant; Organometallic Compounds; Salicylates | 1993 |
A 1-year follow-up study on leakage of four root canal sealers at different thicknesses.
Topics: Animals; Bismuth; Calcium Hydroxide; Cattle; Chi-Square Distribution; Dental Leakage; Drug Combinations; Epoxy Resins; Evaluation Studies as Topic; Glass Ionomer Cements; Methenamine; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Silver; Solubility; Time Factors; Titanium; Water; Zinc Oxide-Eugenol Cement | 1995 |
Evaluation of sealing ability, pH and flow rate of three calcium hydroxide-based sealers.
Topics: Analysis of Variance; Barium Sulfate; Bismuth; Borates; Calcium Hydroxide; Dental Leakage; Drug Combinations; Eugenol; Evaluation Studies as Topic; Humans; Hydrogen-Ion Concentration; Materials Testing; Resins, Synthetic; Rheology; Root Canal Filling Materials; Salicylates; Zinc Oxide | 1995 |
The antimicrobial effect within dentinal tubules of four root canal sealers.
Topics: Analysis of Variance; Animals; Anti-Infective Agents, Local; Bismuth; Calcium Hydroxide; Cattle; Dentin; Drug Combinations; Enterococcus faecalis; Epoxy Resins; Glass Ionomer Cements; Methenamine; Root Canal Filling Materials; Salicylates; Silver; Time Factors; Titanium; Zinc Oxide-Eugenol Cement | 1996 |
Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin.
Topics: Administration, Oral; Animals; Antitoxins; Bismuth; Cholera Toxin; Enzyme-Linked Immunosorbent Assay; Feces; Female; Immunity, Mucosal; Immunization; Immunoglobulin A; Immunoglobulin E; Immunoglobulin G; Mice; Mice, Inbred C57BL; Organometallic Compounds; Salicylates; Sodium Salicylate; Time Factors | 1995 |
Reflections on gastric ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Recurrence; Salicylates; Stomach Ulcer | 1996 |
Photo quiz. Pepto Bismol poisoning.
Topics: Bismuth; Colon; HIV Infections; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Radiography; Salicylates; Self Medication | 1996 |
Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
Topics: Aminoglycosides; Amoxicillin; Antacids; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins; Salicylates; Salicylic Acid | 1996 |
pH changes at the surface of root dentin when using root canal sealers containing calcium hydroxide.
Topics: Bismuth; Calcium Hydroxide; Dentin; Dentin Permeability; Diffusion; Humans; Hydrogen-Ion Concentration; Hydroxyl Radical; Root Canal Filling Materials; Root Resorption; Salicylates; Surface Properties; Tooth Cervix; Tooth Root; Zinc Oxide | 1996 |
Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Salicylates; Stomach Ulcer; Time Factors; Tinidazole | 1996 |
Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Cost of Illness; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Pilot Projects; Salicylates; Tetracycline | 1996 |
Comparative absorption of bismuth in Sprague-Dawley rats following oral administration of preparations containing bismuth sucrose octasulfate, bismuth subsalicylate, and bismuth subcitrate.
Topics: Administration, Oral; Animals; Antacids; Area Under Curve; Bismuth; Intestinal Absorption; Male; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Spectrophotometry, Atomic; Sucrose; Tissue Distribution | 1997 |
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline | 1997 |
In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Helicobacter pylori; Microbial Sensitivity Tests; Organometallic Compounds; Salicylates | 1997 |
Cytoprotective effect of bismuth subsalicylate in indomethacin-treated rats is associated with enhanced mucus bismuth concentration.
Topics: Animals; Bismuth; Blood Flow Velocity; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Indomethacin; Male; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates | 1997 |
Inflammatory response to calcium hydroxide based root canal sealers.
Topics: Animals; Bismuth; Calcium Hydroxide; Chemotaxis, Leukocyte; Connective Tissue; Female; Inflammation; Injections, Intraperitoneal; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Neutrophils; Root Canal Filling Materials; Salicylates; Statistics, Nonparametric; Zinc Oxide | 1997 |
Identification and eradication of Helicobacter pylori in an isolated patient population.
Topics: Amoxicillin; Bismuth; Cost Savings; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Military Personnel; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; United States; Utah | 1997 |
Black granules on the skin after bismuth subsalicylate ingestion.
Topics: Adult; Bismuth; Humans; Male; Organometallic Compounds; Salicylates; Skin | 1997 |
Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Female; Gastric Mucosa; Intestinal Mucosa; Lipid Peroxidation; Luminescent Measurements; Organometallic Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salicylates | 1997 |
Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular?
Topics: Adult; Antacids; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antitrichomonal Agents; Bismuth; Chaperonin 60; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epithelium; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; HLA-DR Antigens; Humans; Immunohistochemistry; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline; Time Factors | 1997 |
Treatment of gastritis in cheetahs (Acinonyx jubatus).
Topics: Acinonyx; Animals; Anti-Bacterial Agents; Antitrichomonal Agents; Biopsy; Bismuth; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Gram-Negative Bacterial Infections; Helicobacter; Helicobacter Infections; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Prospective Studies; Salicylates; Sensitivity and Specificity; Tetracycline; Time Factors | 1997 |
Natural and experimental Helicobacter mustelae reinfection following successful antimicrobial eradication in ferrets.
Topics: Amoxicillin; Animals; Antacids; Bacterial Proteins; Biopsy; Bismuth; DNA, Bacterial; Drug Therapy, Combination; Ferrets; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter; Helicobacter Infections; Metronidazole; Organometallic Compounds; Recurrence; Salicylates; Time Factors; Urease | 1996 |
Characterization and therapy for experimental infection by Helicobacter mustelae in ferrets.
Topics: Amoxicillin; Animals; Antacids; Antibodies, Bacterial; Bismuth; Drug Therapy, Combination; Female; Ferrets; Gastritis; Helicobacter; Helicobacter Infections; Male; Metronidazole; Organometallic Compounds; Salicylates; Specific Pathogen-Free Organisms | 1996 |
Cure of Helicobacter pylori: a hidden curse?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Esophagitis, Peptic; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Risk Factors; Salicylates; Sex Factors; Weight Gain | 1997 |
Calcium hydroxide root canal sealers: evaluation of pH, calcium ion concentration and conductivity.
Topics: Bismuth; Calcium; Calcium Hydroxide; Hydrogen-Ion Concentration; Ion Exchange; Root Canal Filling Materials; Salicylates; Spectrophotometry, Atomic; Zinc Oxide | 1997 |
Relative efficiency of solvents used in endodontics.
Topics: Analysis of Variance; Bismuth; Calcium Hydroxide; Drug Combinations; Epoxy Resins; Gutta-Percha; Humans; Methenamine; Random Allocation; Resins, Synthetic; Root Canal Filling Materials; Root Canal Preparation; Salicylates; Silver; Solubility; Solvents; Time Factors; Titanium; Zinc Oxide | 1998 |
Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Macaca mulatta; Male; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1998 |
Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
Topics: Bismuth; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline | 1998 |
Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon.
Topics: Adult; Animals; Bismuth; Colon; Dose-Response Relationship, Drug; Feces; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Organometallic Compounds; Osmolar Concentration; Rats; Salicylates | 1998 |
Calcium hydroxide root canal sealers--histopathologic evaluation of apical and periapical repair after endodontic treatment.
Topics: Animals; Bicuspid; Bismuth; Calcium Hydroxide; Dogs; Drug Evaluation, Preclinical; Periapical Tissue; Root Canal Filling Materials; Root Canal Therapy; Salicylates; Tooth Apex; Zinc Oxide | 1997 |
Cytotoxicity of four root canal sealers in permanent 3T3 cells and primary human periodontal ligament fibroblast cultures.
Topics: 3T3 Cells; Animals; Biocompatible Materials; Bismuth; Calcium Hydroxide; Cell Division; Cells, Cultured; Coloring Agents; Culture Media; Drug Combinations; Epoxy Resins; Eugenol; Evaluation Studies as Topic; Fibroblasts; Formaldehyde; Gutta-Percha; Humans; Materials Testing; Methenamine; Mice; Periodontal Ligament; Propidium; Root Canal Filling Materials; Salicylates; Silver; Time Factors; Titanium; Zinc Oxide | 1998 |
Physical properties of CH61, a newly developed root canal sealer.
Topics: Bismuth; Calcium Hydroxide; Contrast Media; Dental Leakage; Drug Combinations; Epoxy Resins; Evaluation Studies as Topic; Methenamine; Radiography, Dental; Rheology; Root Canal Filling Materials; Root Canal Therapy; Salicylates; Silver; Solubility; Time Factors; Titanium; Viscosity; Zinc Oxide-Eugenol Cement | 1998 |
Calming ulcerative colitis.
Topics: Bismuth; Colitis, Ulcerative; Humans; Hydrogen Sulfide; Organometallic Compounds; Salicylates | 1998 |
Travelers' diarrhea. Epidemiology, prevention, and self-treatment.
Topics: Antidiarrheals; Bismuth; Diarrhea; Food Microbiology; Humans; Organometallic Compounds; Salicylates; Self Care; Travel; Water Microbiology | 1998 |
Effect of pepper and bismuth subsalicylate on gastric pain and surface hydrophobicity in the rat.
Topics: Animals; Bismuth; Chemical Phenomena; Chemistry, Physical; Diet; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Male; Organometallic Compounds; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Regression Analysis; Salicylates; Spices; Stomach Diseases; Surface Properties | 1998 |
Clinical quiz. Gastrospirillum hominis.
Topics: Bacterial Infections; Bismuth; Child; Gastric Mucosa; Gastritis; Helicobacter heilmannii; Humans; Male; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 1998 |
Clostridium difficile colitis associated with treatment of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Penicillins; Salicylates; Stomach Diseases | 1998 |
The pharmacoeconomic impact of antimicrobial therapy for peptic ulcer disease in a large urban jail.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; New York City; Organometallic Compounds; Peptic Ulcer; Prisons; Ranitidine; Retrospective Studies; Salicylates; Tetracycline; Urban Health | 1998 |
Effect of different root canal sealers on periapical repair of teeth with chronic periradicular periodontitis.
Topics: Animals; Barium Sulfate; Bismuth; Borates; Calcium Hydroxide; Chronic Disease; Dogs; Drug Combinations; Eugenol; Periapical Periodontitis; Resins, Synthetic; Root Canal Filling Materials; Salicylates; Zinc Oxide | 1998 |
Adherence of Acinetobacter baumannii to rat bladder tissue.
Topics: Acinetobacter; Animals; Bacterial Adhesion; Bismuth; Cells, Cultured; Escherichia coli; Galactose; Humans; Mannose; Microscopy, Electron; Organometallic Compounds; Polysaccharides; Rats; Rats, Sprague-Dawley; Salicylates | 1998 |
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Toxins; Bacterial Vaccines; Bismuth; Clarithromycin; Drug Therapy, Combination; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Escherichia coli Proteins; Helicobacter Infections; Helicobacter pylori; Macaca mulatta; Metronidazole; Omeprazole; Organometallic Compounds; Recombinant Proteins; Salicylates; Saliva; Urease | 1999 |
Coronal leakage of two root canal sealers containing calcium hydroxide after exposure to human saliva.
Topics: Bismuth; Calcium Hydroxide; Chi-Square Distribution; Dental Leakage; Dental Pulp Cavity; Humans; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Saliva | 1999 |
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Neoplasm Staging; Omeprazole; Organometallic Compounds; Prospective Studies; Remission Induction; Salicylates; Stomach Neoplasms | 1999 |
Acute and chronic stress-induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate.
Topics: Animals; Bismuth; DNA Fragmentation; Female; Hydroxyl Radical; Intestinal Mucosa; Lipid Peroxidation; Organometallic Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salicylates; Stress, Physiological; Viscosity | 1999 |
Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antigens, Bacterial; Bismuth; Breath Tests; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Sensitivity and Specificity; Urea | 1999 |
Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Chronic Disease; Drug Therapy, Combination; Epidermal Growth Factor; ErbB Receptors; Female; Flow Cytometry; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates | 1999 |
Microscopic colitis syndrome: lymphocytic colitis and collagenous colitis.
Topics: Adult; Bismuth; Chronic Disease; Colitis; Colonoscopy; Diagnosis, Differential; Diarrhea; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Organometallic Compounds; Pancreatic Neoplasms; Prognosis; Salicylates; Vipoma | 1999 |
Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Disease Models, Animal; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lactose; Liver Function Tests; Macaca mulatta; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Sialic Acids | 1999 |
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; L-Lactate Dehydrogenase; Metronidazole; Omeprazole; Organometallic Compounds; Purpura, Thrombocytopenic, Idiopathic; Salicylates; Tetracycline | 1999 |
Mechanism of gastroprotection by bismuth subsalicylate against chemically induced oxidative stress in cultured human gastric mucosal cells.
Topics: Bismuth; Cells, Cultured; Cytochrome c Group; DNA Damage; DNA Fragmentation; Ethanol; Gastric Mucosa; Humans; Hydrochloric Acid; Microscopy, Confocal; Organometallic Compounds; Oxidative Stress; Reactive Oxygen Species; Salicylates; Sodium Hydroxide; Stomach; Superoxides | 1999 |
Comparison of sealing ability of three different root canal sealers--an in vitro study.
Topics: Bismuth; Calcium Hydroxide; Chemical Phenomena; Chemistry, Physical; Chi-Square Distribution; Dental Leakage; Drug Combinations; Epoxy Resins; Humans; Materials Testing; Methenamine; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Silver; Surface Properties; Titanium; Zinc Oxide-Eugenol Cement | 1998 |
Formation of crystals on the surface of calcium hydroxide-containing materials in vitro.
Topics: Bismuth; Calcium Hydroxide; Crystallization; Dental Cements; Dental Materials; Drug Combinations; Electron Probe Microanalysis; Epoxy Resins; Methenamine; Minerals; Root Canal Filling Materials; Salicylates; Silver; Surface Properties; Titanium; Zinc Oxide-Eugenol Cement | 1999 |
Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Chemoprevention; Colombia; Follow-Up Studies; Gastritis, Atrophic; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Penicillins; Precancerous Conditions; Salicylates; Stomach Neoplasms; Treatment Failure; Virulence | 2000 |
Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Treatment Outcome; United States | 2000 |
Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Colitis; Female; Mesalamine; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Trinitrobenzenesulfonic Acid | 2000 |
Pathophysiology and treatment of microscopic-colitis syndrome.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Cattle; Colonic Diseases, Functional; Dogs; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; Rats; Salicylates; Syndrome | 2000 |
Binding of hydrogen sulfide by bismuth does not prevent dextran sulfate-induced colitis in rats.
Topics: Animals; Bismuth; Colitis; Colon; Dextran Sulfate; Feces; Hydrogen Sulfide; Male; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Reference Values; Salicylates | 2000 |
Site of bismuth absorption from bismuth subsalicylate: implications for treatment of colonic conditions.
Topics: Absorption; Administration, Oral; Animals; Bismuth; Cecum; Colonic Diseases; Creatinine; Injections; Male; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates | 2000 |
Collagenous colitis treated successfully with bismuth subsalicylate.
Topics: Aged; Biopsy; Bismuth; Colitis; Collagen; Colon; Female; Humans; Organometallic Compounds; Salicylates | 2000 |
Effect of EDTA on the resistance of clinical isolates of Acinetobacter baumannii to the bactericidal activity of normal human serum.
Topics: Acinetobacter; Bacterial Capsules; Bismuth; Blood Bactericidal Activity; Chelating Agents; Edetic Acid; Humans; Lipopolysaccharides; Organometallic Compounds; Salicylates | 2000 |
Acute gastroenteritis in children.
Topics: Acute Disease; Bismuth; Child; Child, Preschool; Evidence-Based Medicine; Gastroenteritis; Humans; Infant; Organometallic Compounds; Safety; Salicylates; Treatment Outcome | 2000 |
Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Ranitidine; Salicylates | 2000 |
Evaluation of cell culture cytotoxicity of five root canal sealers.
Topics: Animals; Bismuth; Calcium Hydroxide; Cell Membrane; Cell Nucleolus; Cell Nucleus; Cell Size; Cells, Cultured; Chromatin; Cytoplasm; Macrophages, Peritoneal; Rats; Root Canal Filling Materials; Salicylates; Statistics, Nonparametric; Vacuoles; Zinc Oxide; Zinc Oxide-Eugenol Cement | 2000 |
Effect of root canal sealers and irrigation agents on retention of preformed posts luted with a resin cement.
Topics: Acid Etching, Dental; Analysis of Variance; Bicuspid; Bismuth; Cementation; Citric Acid; Dental Stress Analysis; Denture Retention; Disinfectants; Drug Combinations; Epoxy Resins; Eugenol; Fatty Acids; Gutta-Percha; Humans; Incisor; Methenamine; Phosphates; Phosphoric Acids; Post and Core Technique; Resin Cements; Resins, Plant; Root Canal Filling Materials; Root Canal Irrigants; Root Canal Preparation; Salicylates; Silver; Sodium Hypochlorite; Stainless Steel; Stress, Mechanical; Thymol; Titanium; Zinc Oxide | 2000 |
Evaluation of pH and calcium ion release of three root canal sealers.
Topics: Analysis of Variance; Bismuth; Calcium; Calcium Hydroxide; Hydrogen-Ion Concentration; Hydroxyl Radical; Materials Testing; Root Canal Filling Materials; Salicylates; Statistics, Nonparametric | 2000 |
In vitro evaluation of antimicrobial activity of sealers and pastes used in endodontics.
Topics: Adult; Bacteria; Barium Sulfate; Bismuth; Borates; Calcium Chloride; Calcium Hydroxide; Colony Count, Microbial; Dental Leakage; Drug Combinations; Enterococcus faecalis; Epoxy Resins; Escherichia coli; Eugenol; Glass Ionomer Cements; Humans; Immunodiffusion; Microbial Sensitivity Tests; Micrococcus luteus; Potassium Chloride; Pseudomonas aeruginosa; Resins, Synthetic; Root Canal Filling Materials; Salicylates; Saliva; Sodium Bicarbonate; Sodium Chloride; Staphylococcus; Streptococcus mutans; Zinc Oxide | 2000 |
Diminished leakage along root canals filled with gutta-percha without sealer over time: a laboratory study.
Topics: Balsams; Bismuth; Calcium Hydroxide; Dental Leakage; Drug Combinations; Epoxy Resins; Gutta-Percha; Humans; Incisor; Maxilla; Methenamine; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Silver; Statistics, Nonparametric; Time Factors; Titanium; Zinc Oxide; Zinc Oxide-Eugenol Cement | 2000 |
Black tongue.
Topics: Asthma; Bismuth; Female; Gastroesophageal Reflux; Humans; Lupus Erythematosus, Systemic; Middle Aged; Organometallic Compounds; Salicylates; Tongue Diseases | 2001 |
Clinical performance of 3 endodontic sealers.
Topics: Bismuth; Calcium Hydroxide; Follow-Up Studies; Gutta-Percha; Humans; Periapical Periodontitis; Periapical Tissue; Prospective Studies; Radiography; Resins, Synthetic; Root Canal Filling Materials; Root Canal Therapy; Salicylates; Statistics as Topic; Time Factors; Treatment Outcome; Wound Healing; Zinc Oxide; Zinc Oxide-Eugenol Cement | 2001 |
Setting times for endodontic sealers under clinical usage and in vitro conditions.
Topics: Bismuth; Calcium Hydroxide; Drug Combinations; Epoxy Resins; Gutta-Percha; Hardness; Humans; Humidity; Materials Testing; Methenamine; Resin Cements; Root Canal Filling Materials; Root Canal Obturation; Root Canal Preparation; Salicylates; Silver; Surface Properties; Temperature; Time Factors; Titanium; Zinc Oxide-Eugenol Cement | 2001 |
Evaluation of the genotoxicity of zinc oxide eugenol-based, calcium hydroxide-based, and epoxy resin-based root canal sealers by comet assay.
Topics: Analysis of Variance; Bismuth; Calcium Hydroxide; Carcinoma, Squamous Cell; Comet Assay; DNA Damage; Drug Combinations; Epoxy Resins; Humans; Methenamine; Mouth Neoplasms; Root Canal Filling Materials; Salicylates; Silver; Titanium; Tumor Cells, Cultured; Zinc Oxide-Eugenol Cement | 2001 |
Effects of chlorhexidine gluconate as an endodontic irrigant on the apical seal: short-term results.
Topics: Analysis of Variance; Anti-Infective Agents, Local; Bismuth; Calcium Hydroxide; Chlorhexidine; Dental Leakage; Drug Combinations; Epoxy Resins; Humans; Methenamine; Root Canal Filling Materials; Root Canal Irrigants; Salicylates; Silver; Titanium; Zinc Oxide-Eugenol Cement | 2001 |
Antimicrobial activity of four root canal sealers against endodontic pathogens.
Topics: Analysis of Variance; Anti-Bacterial Agents; Bacteria, Anaerobic; Bismuth; Calcium Hydroxide; Dental Pulp Diseases; Drug Combinations; Epoxy Resins; Escherichia coli; Eugenol; Formaldehyde; Fusobacterium nucleatum; Humans; Materials Testing; Methenamine; Porphyromonas; Porphyromonas gingivalis; Prevotella intermedia; Root Canal Filling Materials; Salicylates; Silver; Staphylococcus aureus; Statistics as Topic; Streptococcus mutans; Streptococcus sanguis; Titanium; Zinc Oxide; Zinc Oxide-Eugenol Cement | 2001 |
Drug prophylaxis for travelers' diarrhea.
Topics: 4-Quinolones; Anti-Infective Agents; Antibiotic Prophylaxis; Bismuth; Diarrhea; Escherichia coli Infections; Humans; Organometallic Compounds; Probiotics; Salicylates; Travel | 2002 |
Cytotoxicity of resin-, zinc oxide-eugenol-, and calcium hydroxide-based root canal sealers on human periodontal ligament cells and permanent V79 cells.
Topics: Administration, Topical; Analysis of Variance; Animals; Anti-Inflammatory Agents; Bismuth; Calcium Hydroxide; Cells, Cultured; Cricetinae; Dexamethasone; Drug Combinations; Epoxy Resins; Fibroblasts; Formaldehyde; Humans; Hydrocortisone; Methenamine; Periodontal Ligament; Resin Cements; Root Canal Filling Materials; Salicylates; Silver; Statistics, Nonparametric; Thymol; Titanium; Zinc Oxide-Eugenol Cement | 2002 |
Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.
Topics: Animals; Bismuth; Disease Models, Animal; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mice; Mice, Inbred C57BL; Organometallic Compounds; Salicylates; Tetracycline | 2002 |
Calcium salts deposition in rat connective tissue after the implantation of calcium hydroxide-containing sealers.
Topics: Aluminum Compounds; Animals; Birefringence; Bismuth; Calcium Compounds; Calcium Hydroxide; Connective Tissue; Dentin; Dentin, Secondary; Drug Combinations; Humans; Oxides; Rats; Root Canal Filling Materials; Salicylates; Silicates; Zinc Oxide | 2002 |
Anaphylaxis to Pepto-Bismol.
Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Hypersensitivity; Humans; Immunoglobulin E; Male; Organometallic Compounds; Reproducibility of Results; Salicylates; Skin Tests; United States; Urticaria | 2002 |
Sealer distribution in coronal dentin.
Topics: Bismuth; Calcium Hydroxide; Dentin; Dentin Permeability; Drug Combinations; Epoxy Resins; Humans; Random Allocation; Root Canal Filling Materials; Salicylates; Silver; Titanium; Tooth Crown; Tooth Discoloration; Zinc Oxide-Eugenol Cement | 2002 |
Evaluation of the effect of EDTA, EGTA and CDTA on dentin adhesiveness and microleakage with different root canal sealers.
Topics: Adhesiveness; Analysis of Variance; Bismuth; Calcium Hydroxide; Carbon; Chelating Agents; Coloring Agents; Cuspid; Dental Bonding; Dental Leakage; Dentin; Edetic Acid; Egtazic Acid; Humans; Humidity; Molar; Root Canal Filling Materials; Root Canal Obturation; Root Canal Preparation; Salicylates; Statistics as Topic; Temperature; Time Factors | 2002 |
Bismuth subsalicylate in the cecum.
Topics: Aged; Aged, 80 and over; Bismuth; Cecal Diseases; Cecum; Colonoscopy; Female; Humans; Organometallic Compounds; Radiography, Abdominal; Salicylates; Treatment Outcome | 2002 |
Adhesion of endodontic sealers to dentin and gutta-percha.
Topics: Adhesiveness; Analysis of Variance; Bismuth; Calcium Hydroxide; Dental Bonding; Dental Cements; Dental Pulp Cavity; Dentin; Drug Combinations; Epoxy Resins; Glass Ionomer Cements; Gutta-Percha; Humans; Humidity; Materials Testing; Root Canal Filling Materials; Salicylates; Silver; Statistics as Topic; Stress, Mechanical; Surface Properties; Temperature; Tensile Strength; Time Factors; Titanium; Zinc Oxide-Eugenol Cement | 2002 |
Towards a molecular model for bismuth(III) subsalicylate. Synthesis and solid-state structure of [Bi(Hsal)3(bipy)(C7H8]2 and [Bi(Hsal)(sal)(1,10-phenanthroline)(C7H8]2.
Topics: Amines; Bismuth; Ligands; Models, Molecular; Molecular Structure; Organometallic Compounds; Phenanthrolines; Salicylates | 2002 |
In vitro cytotoxicity evaluation of endodontic sealers exposed to heat before assay.
Topics: Adhesiveness; Adolescent; Adult; Analysis of Variance; Bismuth; Calcium Hydroxide; Cell Adhesion; Cell Division; Cells, Cultured; Drug Combinations; Epoxy Resins; Female; Fibroblasts; Gingiva; Hot Temperature; Humans; Root Canal Filling Materials; Salicylates; Silver; Statistics, Nonparametric; Titanium; Toxicity Tests; Zinc Oxide-Eugenol Cement | 2002 |
The effect of chlorhexidine gluconate as an endodontic irrigant on the apical seal: long-term results.
Topics: Analysis of Variance; Anti-Infective Agents, Local; Bismuth; Calcium Hydroxide; Chlorhexidine; Dental Leakage; Drug Combinations; Epoxy Resins; Gutta-Percha; Humans; Materials Testing; Root Canal Filling Materials; Root Canal Irrigants; Salicylates; Silver; Sodium Hypochlorite; Statistics, Nonparametric; Titanium; Tooth Apex; Zinc Oxide-Eugenol Cement | 2003 |
Rheological properties and biocompatibility of endodontic sealers.
Topics: Analysis of Variance; Animals; Bismuth; Calcium Hydroxide; Dexamethasone; Drug Combinations; Epoxy Resins; Fibroblasts; Foreign-Body Reaction; Formaldehyde; Glass Ionomer Cements; Hydrocortisone; Materials Testing; Rats; Rats, Wistar; Resins, Synthetic; Rheology; Root Canal Filling Materials; Salicylates; Silver; Skin; Statistics, Nonparametric; Thymol; Titanium; Viscosity; Zinc Oxide; Zinc Oxide-Eugenol Cement | 2003 |
[Treatment of collagenous colitis. An analysis of a systematic Cochrane review].
Topics: Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates | 2003 |
Antiluetic Therapy for Erythroblastosis Prophylaxis.
Topics: Antacids; Antidiarrheals; Bismuth; Erythroblastosis, Fetal; Hematologic Diseases; Humans; Salicylates | 1955 |
[ON A CASE OF SYPHILITIC PSEUDI-TUMOR OF THE STOMACH].
Topics: Antacids; Bismuth; Diagnosis, Differential; Hodgkin Disease; Humans; Neoplasms; Penicillins; Radiography; Salicylates; Stomach; Stomach Neoplasms; Syphilis; Syphilis Serodiagnosis | 1963 |
DRUG REACTIONS INVOLVING THE ALIMENTARY TRACT.
Topics: Anticoagulants; Bismuth; Chemical and Drug Induced Liver Injury; Chlorothiazide; Drug Therapy; Esophagus; Gastroenterology; Hepatitis; Intestinal Diseases; Mercury Poisoning; Morphine; Mouth; Pancreas; Phenylbutazone; Phenytoin; Reserpine; Salicylates; Steroids; Stomach; Tooth; Toxicology | 1964 |
[Pediatric practice. Special risks of various drugs. II. Asprin and salicylates, bismuth subnitrate].
Topics: Antacids; Antidiarrheals; Aspirin; Bismuth; Humans; Nitrates; Risk; Salicylates | 1962 |
Solubility of root-canal sealers in water and artificial saliva.
Topics: Analysis of Variance; Bismuth; Calcium Hydroxide; Dental Cements; Drug Combinations; Epoxy Resins; Glass Ionomer Cements; Humans; Hydrogen-Ion Concentration; Matched-Pair Analysis; Materials Testing; Polyvinyls; Root Canal Filling Materials; Salicylates; Saliva, Artificial; Silver; Solubility; Time Factors; Titanium; Water; Zinc Oxide; Zinc Oxide-Eugenol Cement | 2003 |
In vitro evaluation of the dissolving effect of solvents on root canal sealers.
Topics: Analysis of Variance; Bismuth; Calcium Hydroxide; Calcium Phosphates; Chloroform; Dental Cements; Drug Combinations; Durapatite; Epoxy Resins; Eugenol; Halothane; Materials Testing; Polyvinyls; Retreatment; Root Canal Filling Materials; Salicylates; Silver; Solubility; Solvents; Titanium; Zinc Oxide | 2003 |
Intracanal distribution patterns of sealers after lateral condensation.
Topics: Bismuth; Calcium Hydroxide; Dental Leakage; Drug Combinations; Epoxy Resins; Gutta-Percha; Humans; Root Canal Filling Materials; Root Canal Obturation; Salicylates; Silver; Titanium; Zinc Oxide-Eugenol Cement | 2003 |
Treatment of early syphilis with penicillin and bismuth subsalicylate: daily injection of 500,000 units of penicillin G in sodium chloride solution for twenty consecutive days and ten to twenty doses of bismuth subsalicylate at the rate of two a week; sec
Topics: Antacids; Bismuth; Organometallic Compounds; Penicillin G; Penicillins; Salicylates; Sodium Chloride; Syphilis | 1950 |
Penicillin in the treatment of experimental syphilis of rabbits. VII. Penicillin "S-R" and procaine penicillin G in peanut oil with aluminum monostearate, alone and in combination with oxophenarsine hydrochloride (mapharsen) or bismuth subsalicylate.
Topics: Animals; Arsenicals; Bismuth; Organometallic Compounds; Peanut Oil; Penicillin G Procaine; Penicillins; Plant Oils; Rabbits; Salicylates; Stearic Acids; Syphilis | 1951 |
Bismuth salicylate in the treatment of yaws.
Topics: Bismuth; Salicylates; Yaws | 1951 |
Adsorption characteristics of aureomycin and terramycin on aluminum hydroxide gel and on a bismuth subsalicylate preparation.
Topics: Adsorption; Aluminum Hydroxide; Antacids; Antidiarrheals; Bismuth; Chlortetracycline; Organometallic Compounds; Oxytetracycline; Salicylates | 1952 |
The treatment of early syphilis with penicillin and bismuth subsalicylate; follow-up report.
Topics: Antacids; Antidiarrheals; Bismuth; Follow-Up Studies; Organometallic Compounds; Penicillins; Salicylates; Syphilis | 1952 |
Bismuth subsalicylate increases intracellular Ca2+, MAP-kinase activity, and cell proliferation in normal human gastric mucous epithelial cells.
Topics: Acetates; Bismuth; Blotting, Western; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Flavonoids; Gastric Mucosa; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Organometallic Compounds; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Calcium-Sensing; Salicylates; Signal Transduction | 2004 |
The treatment of acute syphilitic orchitis and generalized syphilis of rabbits with repository penicillin products alone and in combination with mapharsen and bismuth salicylate.
Topics: Animals; Antacids; Antidiarrheals; Arsenic; Arsenicals; Bismuth; Humans; Male; Orchitis; Penicillins; Rabbits; Salicylates; Syphilis; Testis | 1950 |
Treatment of early syphilis with penicillin and bismuth subsalicylate; daily injection of 500,000 units of penicillin G in sodium chloride solution for 20 consecutive days and 10 to 20 doses of bismuth subsalicylate at the rate of two a week.
Topics: Antacids; Bismuth; Organometallic Compounds; Penicillin G; Penicillins; Salicylates; Sodium Chloride; Syphilis | 1950 |
Tryparsamide and bismuth subsalicylate in the treatment of experimental syphilis of rabbits; synergistic or additive activity.
Topics: Animals; Antacids; Arsenicals; Bismuth; Organometallic Compounds; Rabbits; Salicylates; Syphilis | 1950 |
Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile.
Topics: Anti-Bacterial Agents; Ascorbic Acid; Beverages; Bismuth; Clostridioides difficile; Drug Interactions; Fruit; Humans; Microbial Sensitivity Tests; Organometallic Compounds; Salicylates; Sulfhydryl Compounds | 2005 |
Metabolism of bismuth subsalicylate and intracellular accumulation of bismuth by Fusarium sp. strain BI.
Topics: Biomass; Bismuth; Culture Media; Fusarium; Glucose; Microscopy, Electron, Transmission; Molecular Sequence Data; Organometallic Compounds; Peptide Elongation Factor 1; RNA, Ribosomal, 18S; Salicylates; Sequence Analysis, DNA; Tubulin | 2005 |
Managing diarrhea in infants.
Topics: Bismuth; Diarrhea, Infantile; Fluid Therapy; Humans; Infant; Organometallic Compounds; Salicylates | 2005 |
In vitro antimicrobial activity of Fill Canal, Sealapex, Mineral Trioxide Aggregate, Portland cement and EndoRez.
Topics: Aluminum Compounds; Anti-Infective Agents; Bacteria; Barium Sulfate; Bismuth; Borates; Calcium Compounds; Calcium Hydroxide; Candida albicans; Composite Resins; Drug Combinations; Enterococcus faecalis; Escherichia coli; Eugenol; Humans; Materials Testing; Micrococcus luteus; Oxides; Pseudomonas aeruginosa; Resins, Synthetic; Root Canal Filling Materials; Salicylates; Silicates; Staphylococcus aureus; Staphylococcus epidermidis; Zinc Oxide | 2005 |
[Plant sulfate assimilation and regulation of the activity of related enzymes under cadmium stress].
Topics: Bismuth; Cadmium; Gene Expression Regulation, Plant; Organometallic Compounds; Oxidoreductases Acting on Sulfur Group Donors; Phytochelatins; Plants; Salicylates; Sulfate Adenylyltransferase; Sulfates | 2006 |
Salicylate toxicity associated with administration of Percy medicine in an infant.
Topics: Bismuth; Colic; Humans; Infant; Male; Organometallic Compounds; Salicylates | 2006 |
Pityriasis rosea-like eruption due to bismuth.
Topics: Aged; Bismuth; Diagnosis, Differential; Drug Eruptions; Female; Humans; Organometallic Compounds; Pityriasis Rosea; Salicylates | 2006 |
Can I prevent travelers' diarrhea by taking antibiotics before my trip?
Topics: Antibiotic Prophylaxis; Bismuth; Diarrhea; Humans; Organometallic Compounds; Salicylates; Travel | 2006 |
Evaluation of periapical repair following retrograde filling with different root-end filling materials in dog teeth with periapical lesions.
Topics: Aluminum Compounds; Animals; Bismuth; Calcium Compounds; Calcium Hydroxide; Dogs; Drug Combinations; Female; Male; Oxides; Periapical Periodontitis; Retrograde Obturation; Root Canal Filling Materials; Salicylates; Silicates; Statistics, Nonparametric; Wound Healing | 2006 |
Towards a structural understanding of the anti-ulcer and anti-gastritis drug bismuth subsalicylate.
Topics: Anti-Ulcer Agents; Bismuth; Crystallography, X-Ray; Gastritis; Models, Molecular; Molecular Structure; Organometallic Compounds; Salicylates | 2006 |
Find out what's behind that fuzzy-looking, black tongue.
Topics: Bismuth; Dentists; Drug-Related Side Effects and Adverse Reactions; Humans; Mouth Diseases; Organometallic Compounds; Professional Role; Salicylates; Tongue, Hairy | 2006 |
Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Retrospective Studies; Salicylates; Treatment Outcome | 2006 |
What is your diagnosis? A bismuth subsalicylate tablet in the stomach.
Topics: Animals; Bismuth; Chelating Agents; Dog Diseases; Dogs; Female; Foreign Bodies; Organometallic Compounds; Radiography, Abdominal; Salicylates; Tablets; Treatment Outcome; Vomiting | 2007 |
Cooperative influence of thiolate ligands on the bio-relevant coordination chemistry of bismuth.
Topics: Amino Acids; Bismuth; Cysteine; Glycine; Molecular Structure; Organometallic Compounds; Picolinic Acids; Salicylates; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds | 2007 |
Case of the month. Obstipation.
Topics: Abdominal Pain; Adult; Bismuth; Constipation; Fecal Impaction; Humans; Male; Organometallic Compounds; Radiography; Salicylates | 2007 |
Evaluation of the radiopacity of calcium hydroxide- and glass-ionomer-based root canal sealers.
Topics: Absorptiometry, Photon; Acrylic Resins; Aluminum Silicates; Bismuth; Calcium Hydroxide; Contrast Media; Glass Ionomer Cements; Humans; Image Processing, Computer-Assisted; Materials Testing; Radiographic Image Enhancement; Root Canal Filling Materials; Salicylates; Zinc Oxide-Eugenol Cement | 2008 |
Effects of root canal sealers on lipopolysaccharide-induced expression of cyclooxygenase-2 mrna in murine macrophage cells.
Topics: Animals; Bismuth; Calcium Hydroxide; Cell Line; Cell Survival; Cyclooxygenase 2; Drug Combinations; Drug Synergism; Epoxy Resins; Inflammation; Lipopolysaccharides; Macrophages; Mice; RNA, Messenger; Root Canal Filling Materials; Salicylates; Silver; Titanium | 2007 |
Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Colombia; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Organometallic Compounds; Precancerous Conditions; Regression Analysis; Salicylates; Smoking; Treatment Failure | 2007 |
The effect of starvation stress on the protein profiles in Flexibacter chinensis.
Topics: Amino Acid Sequence; Bacterial Proteins; Bismuth; Carbon; Electrophoresis, Gel, Two-Dimensional; Escherichia coli; Flexibacter; Gene Expression Regulation, Bacterial; Molecular Sequence Data; Nitrogen; Organometallic Compounds; Oxidative Stress; Phosphates; Salicylates; Temperature; Time Factors | 2008 |
[Topic: Treating travelers' diarrhea. When should medication be given?].
Topics: Adult; Anti-Bacterial Agents; Antidiarrheals; Atropine; Bismuth; Child; Cross-Sectional Studies; Diarrhea; Diphenoxylate; Drug Combinations; Dysentery; Fluid Therapy; Fluoroquinolones; Humans; Loperamide; Organometallic Compounds; Probiotics; Risk Factors; Salicylates; Travel | 2008 |
Mucosal tear in collagenous colitis.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antidiarrheals; Biopsy; Bismuth; Budesonide; Ciprofloxacin; Colitis, Collagenous; Colonoscopy; Enema; Female; Humans; Intestinal Mucosa; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Treatment Outcome | 2009 |
Notched stress-strain behavior of a conventional and a sequentially annealed highly crosslinked UHMWPE.
Topics: Biocompatible Materials; Bismuth; Compressive Strength; Cross-Linking Reagents; Materials Testing; Organometallic Compounds; Polyethylenes; Prostheses and Implants; Salicylates; Tensile Strength | 2008 |
Characterization of an outbreak of astroviral diarrhea in a group of cheetahs (Acinonyx jubatus).
Topics: Acinonyx; Animals; Antidiarrheals; Astroviridae; Astroviridae Infections; Base Sequence; Bismuth; Capsid Proteins; Disease Outbreaks; Feces; Female; Microscopy, Electron, Transmission; Molecular Sequence Data; Organometallic Compounds; Phylogeny; Reverse Transcriptase Polymerase Chain Reaction; RNA-Dependent RNA Polymerase; RNA, Viral; Salicylates; Vipoma | 2009 |
Antimicrobial activity of endodontic sealers based on calcium hydroxide and MTA.
Topics: Aluminum Compounds; Anti-Infective Agents; Bismuth; Calcium Compounds; Calcium Hydroxide; Candida albicans; Colony Count, Microbial; Drug Combinations; Enterococcus faecalis; Humans; Materials Testing; Micrococcus luteus; Oxides; Pseudomonas aeruginosa; Root Canal Filling Materials; Salicylates; Silicates; Staphylococcus aureus; Temperature; Time Factors; Zinc Oxide-Eugenol Cement | 2008 |
In vitro evaluation of the antimicrobial activity of nine root canal sealers: direct contact test.
Topics: Anti-Infective Agents; Bismuth; Calcium Hydroxide; Candida albicans; Composite Resins; Drug Combinations; Enterococcus faecalis; Epoxy Resins; Humans; Materials Testing; Microbial Sensitivity Tests; Resin Cements; Root Canal Filling Materials; Salicylates; Silver; Spectrophotometry; Staphylococcus aureus; Time Factors; Titanium; Zinc Oxide-Eugenol Cement | 2008 |
[Effects of fluid shear stress time on carbonic anhydrase in rat osteoclasts].
Topics: Animals; Bismuth; Carbonic Anhydrases; Cells, Cultured; Organometallic Compounds; Osteoclasts; Rats; RNA, Messenger; Salicylates; Stress, Mechanical | 2009 |
Bismuth(III) 5-sulfosalicylate complexes: structure, solubility and activity against Helicobacter pylori.
Topics: Bismuth; Crystallography, X-Ray; Helicobacter pylori; Molecular Conformation; Organometallic Compounds; Salicylates; Solubility; Temperature | 2009 |
Crohn's colitis with perianal disease complicated by collagenous colitis: discourse on management options.
Topics: Antidiarrheals; Bismuth; Colitis; Colitis, Collagenous; Crohn Disease; Drug Therapy, Combination; Female; Humans; Loperamide; Middle Aged; Organometallic Compounds; Psychoses, Substance-Induced; Rectal Fistula; Salicylates; Steroids | 2010 |
Bismuth-doped injectable calcium phosphate cement with improved radiopacity and potent antimicrobial activity for root canal filling.
Topics: Anti-Infective Agents; Bismuth; Calcium Phosphates; Compressive Strength; Dental Cements; Dental Pulp Cavity; Humans; Injections; Materials Testing; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Radiography; Root Canal Filling Materials; Salicylates; Staphylococcus aureus; Tooth; Viscosity; X-Ray Diffraction | 2010 |
The kaopectate-paregoric incompatibility.
Topics: Bismuth; Humans; Opium; Organometallic Compounds; Salicylates; Stomach | 1947 |
The relative toxicity and therapeutic activity in experimental syphilis of bismuth subsalicylate, bismosol, and biliposol.
Topics: Bismuth; Organometallic Compounds; Salicylates; Syphilis | 1946 |
Tissue necrosis from injection of bismuth subsalicylate in vegetable oil.
Topics: Antacids; Antidiarrheals; Bismuth; Humans; Injections; Organometallic Compounds; Plant Oils; Salicylates | 1946 |
Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Humans; Organometallic Compounds; Proton Pump Inhibitors; Salicylates | 2010 |
Bismuth subsalicylate in oil; the treatment of choice in Vincent's angina.
Topics: Bismuth; Fusobacterium Infections; Gingivitis, Necrotizing Ulcerative; Organometallic Compounds; Salicylates | 1946 |
Bismuth subsalicylate in oil the treatment of choice in Vincent's angina.
Topics: Antacids; Bismuth; Fusobacterium Infections; Gingivitis, Necrotizing Ulcerative; Organometallic Compounds; Salicylates | 1946 |
Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Bismuth; Cathelicidins; Cell Wall; Cholesterol; DNA Replication; Drug Resistance, Bacterial; Folic Acid; Helicobacter pylori; Hydrophobic and Hydrophilic Interactions; Lipid A; Monomeric GTP-Binding Proteins; Organometallic Compounds; Phosphoric Monoester Hydrolases; Protein Synthesis Inhibitors; Salicylates | 2011 |
Mechanosynthesis of the metallodrug bismuth subsalicylate from Bi2O3 and structure of bismuth salicylate without auxiliary organic ligands.
Topics: Bismuth; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Organometallic Compounds; Salicylates | 2011 |
Biocompatibility of sealers used in apical surgery: a histological study in rat subcutaneous tissue.
Topics: Aluminum Compounds; Animals; Biocompatible Materials; Bismuth; Calcium Compounds; Calcium Hydroxide; Cellulitis; Drug Combinations; Giant Cells; Granuloma, Foreign-Body; Lymphocytes; Macrophages; Male; Materials Testing; Necrosis; Oxides; Rats; Rats, Wistar; Root Canal Filling Materials; Salicylates; Silicates; Subcutaneous Tissue; Time Factors; Viscosity; Zinc Oxide | 2011 |
Changes in the surface of four calcium silicate-containing endodontic materials and an epoxy resin-based sealer after a solubility test.
Topics: Aluminum Compounds; Bismuth; Calcium; Calcium Compounds; Calcium Hydroxide; Carbon; Dental Cements; Drug Combinations; Electron Probe Microanalysis; Epoxy Resins; Humans; Lead; Materials Testing; Microscopy, Electron, Scanning; Nickel; Oxides; Potassium; Root Canal Filling Materials; Salicylates; Silicates; Sodium; Solubility; Spectrometry, X-Ray Emission; Spectrophotometry, Atomic; Surface Properties; Water; Zinc | 2012 |
In vivo differentiation of complementary contrast media at dual-energy CT.
Topics: Administration, Oral; Animals; Bismuth; Contrast Media; Feasibility Studies; Image Processing, Computer-Assisted; Injections, Intravenous; Iohexol; Organometallic Compounds; Phantoms, Imaging; Rabbits; Salicylates; Tomography, X-Ray Computed; Tungsten Compounds | 2012 |
Evaluation of apical sealing ability of four different sealers using centrifuging dye penetration method: an in vitro study.
Topics: Barium Sulfate; Bismuth; Calcium Hydroxide; Centrifugation; Coloring Agents; Dental Bonding; Dental Cements; Dental Leakage; Drug Combinations; Edetic Acid; Epoxy Resins; Humans; Humidity; Hydrocarbons, Iodinated; Materials Testing; Methylene Blue; Polyvinyls; Root Canal Filling Materials; Root Canal Irrigants; Root Canal Obturation; Root Canal Preparation; Salicylates; Silver; Sodium Hypochlorite; Temperature; Time Factors; Titanium; Tooth Apex; Zinc Oxide; Zinc Oxide-Eugenol Cement | 2012 |
Antibiofilm activity, pH and solubility of endodontic sealers.
Topics: Acrylic Resins; Aluminum Compounds; Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Bismuth; Calcium Compounds; Calcium Hydroxide; Cattle; Dentin; Drug Combinations; Enterococcus faecalis; Epoxy Resins; Hydrogen-Ion Concentration; Materials Testing; Oxides; Root Canal Filling Materials; Salicylates; Silicates; Solubility; Time Factors; Water | 2013 |
Single-site bismuth alkoxide catalysts for the ring-opening polymerization of lactide.
Topics: Bismuth; Catalysis; Coordination Complexes; Crystallography, X-Ray; Dioxanes; Ethylenediamines; Kinetics; Molecular Conformation; Organometallic Compounds; Polyesters; Salicylates | 2013 |
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Chlorides; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Peptic Ulcer; Salicylates; Zinc Compounds | 2014 |
Bismuth salicylate for diarrhea in children.
Topics: Antidiarrheals; Bismuth; Child; Cost-Benefit Analysis; Developing Countries; Diarrhea; Evidence-Based Medicine; Humans; Organometallic Compounds; Reye Syndrome; Salicylates | 2013 |
Inadvertent exaggerated anticoagulation following use of bismuth subsalicylate in an enterally fed patient receiving warfarin therapy.
Topics: Anticoagulants; Bismuth; Drug Interactions; Enteral Nutrition; Female; Humans; International Normalized Ratio; Middle Aged; Organometallic Compounds; Salicylates; Warfarin | 2013 |
Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: role of nitric oxide and hydrogen sulfide.
Topics: Adipose Tissue; Alkynes; Animals; Biological Factors; Bismuth; Cystathionine gamma-Lyase; Diet; Endothelium, Vascular; Gene Expression Regulation; Glycine; Hydrogen Sulfide; Leptin; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Organometallic Compounds; Phenylephrine; Rats; Rats, Wistar; Receptors, Leptin; Salicylates; Signal Transduction; Tissue Culture Techniques; Vasoconstriction; Vasodilation | 2014 |
Renal pigmentation due to chronic bismuth administration in a rhesus macaque (Macaca mulatta).
Topics: Animals; Antiemetics; Bismuth; Kidney; Kidney Diseases; Macaca mulatta; Male; Monkey Diseases; Organometallic Compounds; Pigmentation; Pigmentation Disorders; Salicylates; Vomiting | 2015 |
What is your diagnosis? Obstructive intestinal foreign body.
Topics: Animals; Bismuth; Dog Diseases; Dogs; Foreign Bodies; Intestinal Obstruction; Male; Organometallic Compounds; Salicylates; Tablets; Textiles | 2015 |
Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.
Topics: Animals; Anti-Infective Agents; Bacterial Load; Bismuth; Clostridioides difficile; Enterobacteriaceae; Humans; Mice; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Norovirus; Organometallic Compounds; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Salicylates; Viral Load; Viral Plaque Assay | 2015 |
Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Female; Humans; Logistic Models; Male; Middle Aged; Organometallic Compounds; Salicylates; Tertiary Care Centers; Treatment Outcome | 2015 |
Effects of the association of antifungal drugs on the antimicrobial action of endodontic sealers.
Topics: Antifungal Agents; Bismuth; Calcium Hydroxide; Candida albicans; Epoxy Resins; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Root Canal Filling Materials; Salicylates; Statistics, Nonparametric | 2015 |
Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area.
Topics: Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prognosis; Salicylates; Thailand | 2015 |
Mitigation of in vitro hydrogen sulfide production using bismuth subsalicylate with and without monensin in beef feedlot diets.
Topics: Animal Feed; Animals; Bismuth; Cattle; Diet; Digestion; Fermentation; Hydrogen; Hydrogen Sulfide; Monensin; Organometallic Compounds; Rumen; Salicylates | 2015 |
Dissolution of a mineral trioxide aggregate sealer in endodontic solvents compared to conventional sealers.
Topics: Aluminum Compounds; Analysis of Variance; Bismuth; Calcium Compounds; Calcium Hydroxide; Chloroform; Cyclohexanols; Drug Combinations; Epoxy Resins; Eucalyptol; Immersion; Materials Testing; Monoterpenes; Oxides; Reference Values; Reproducibility of Results; Root Canal Filling Materials; Salicylates; Silicates; Silver; Solubility; Solvents; Time Factors; Titanium; Ultrasonic Waves; Zinc Oxide-Eugenol Cement | 2016 |
Volume of sealer in the apical region of teeth filled by different techniques: a micro-CT analysis.
Topics: Bismuth; Calcium Hydroxide; Epoxy Resins; Gutta-Percha; Humans; Imaging, Three-Dimensional; Materials Testing; Random Allocation; Reproducibility of Results; Root Canal Filling Materials; Root Canal Preparation; Salicylates; Statistics, Nonparametric; X-Ray Microtomography | 2016 |
Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bismuth; Canada; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Salvage Therapy; Tetracycline; Treatment Failure; Treatment Outcome; Young Adult | 2016 |
Sulfate-reducing bacteria slow intestinal transit in a bismuth-reversible fashion in mice.
Topics: Animals; Bismuth; Desulfovibrio vulgaris; Female; Gastrointestinal Transit; Hydrogen Sulfide; Intestine, Small; Mice; Mice, Inbred C57BL; Organometallic Compounds; Random Allocation; Salicylates | 2017 |
Barry Marshall, MD: H pylori 35 Years Later.
Topics: Anniversaries and Special Events; Antacids; Anti-Bacterial Agents; Asthma; Bacterial Vaccines; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nobel Prize; Organometallic Compounds; Peptic Ulcer; Probiotics; Salicylates; Stress, Psychological | 2017 |
Case 1: Mysteriously Rising Salicylate Levels in a 15-year-old Girl.
Topics: Adolescent; Bezoars; Biomarkers; Bismuth; Female; Humans; Organometallic Compounds; Radiography; Salicylates; Stomach; Suicide, Attempted | 2017 |
Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications.
Topics: Aggregatibacter actinomycetemcomitans; Anaerobiosis; Anti-Bacterial Agents; Bismuth; Cell Line; Cell Survival; Drug Compounding; Fibroblasts; Gingiva; Humans; L-Lactate Dehydrogenase; Microbial Sensitivity Tests; Nanoparticles; Organometallic Compounds; Porphyromonas gingivalis; Salicylates | 2017 |
Lymphocytic colitis: pathologic predictors of response to therapy.
Topics: Adult; Aged; Aged, 80 and over; Antidiarrheals; Biopsy; Bismuth; Colitis, Lymphocytic; Collagen; Female; Humans; Male; Mesalamine; Middle Aged; Organometallic Compounds; Salicylates; Steroids; Treatment Outcome | 2018 |
Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Doxycycline; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell; Metronidazole; Middle Aged; Organometallic Compounds; Rabeprazole; Salicylates | 2018 |
Bismuth Subsalicylate Coagulopathy in a Patient with Chronic Liver Disease.
Topics: Bismuth; Blood Coagulation Disorders; Chronic Disease; Female; Humans; International Normalized Ratio; Liver Cirrhosis; Middle Aged; Organometallic Compounds; Salicylates | 2019 |
Bismuth encephalopathy- a rare complication of long-standing use of bismuth subsalicylate.
Topics: Adult; Bismuth; Brain Diseases; Female; Humans; Neurotoxicity Syndromes; Organometallic Compounds; Salicylates | 2019 |
Mucoadhesive effect of Curcuma longa extract and curcumin decreases the ranitidine effect, but not bismuth subsalicylate on ethanol-induced ulcer model.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Curcuma; Curcumin; Disease Models, Animal; Drug Interactions; Ethanol; Gastric Mucosa; Herb-Drug Interactions; Male; Organometallic Compounds; Plant Extracts; Ranitidine; Rats; Rats, Wistar; Salicylates; Stomach Ulcer | 2019 |
Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
Topics: Aged, 80 and over; Anemia; Antidiarrheals; Betacoronavirus; Bismuth; Blood Sedimentation; C-Reactive Protein; Coronavirus Infections; Cough; COVID-19; Crohn Disease; Diarrhea; Humans; Lymphopenia; Male; Organometallic Compounds; Pandemics; Pneumonia, Viral; Salicylates; SARS-CoV-2; Treatment Outcome | 2020 |
Use of the Multiplex Diagnostic PCR Panel in Diarrheal Disease: Expert Guidance on the Interpretation of Results With a Focus on Travelers' Diarrhea.
Topics: Anti-Bacterial Agents; Antidiarrheals; Antiprotozoal Agents; Bismuth; Campylobacter Infections; Dysentery; Enteropathogenic Escherichia coli; Escherichia coli; Escherichia coli Infections; Giardiasis; Humans; Loperamide; Multiplex Polymerase Chain Reaction; Organometallic Compounds; Salicylates; Shiga-Toxigenic Escherichia coli; Travel-Related Illness | 2020 |
Effects of bismuth subsalicylate and encapsulated calcium ammonium nitrate on ruminal fermentation of beef cattle.
Topics: Animal Feed; Animals; Bismuth; Cattle; Diet; Dietary Supplements; Digestion; Fermentation; Male; Molasses; Nitrates; Nitrogen; Organometallic Compounds; Paspalum; Quaternary Ammonium Compounds; Rumen; Saccharum; Salicylates; Urea | 2020 |
Effects of bismuth subsalicylate and encapsulated calcium-ammonium nitrate on enteric methane production, nutrient digestibility, and liver mineral concentration of beef cattle.
Topics: Animal Feed; Animals; Bismuth; Cattle; Diet; Dietary Supplements; Digestion; Female; Gastrointestinal Tract; Liver; Male; Methane; Minerals; Molasses; Nitrates; Nutrients; Organometallic Compounds; Paspalum; Quaternary Ammonium Compounds; Random Allocation; Saccharum; Salicylates; Urea | 2020 |
Salicylate toxicity from chronic bismuth subsalicylate use.
Topics: Accidental Falls; Aged; Bismuth; Confusion; Diagnosis, Differential; Hearing Disorders; Humans; Male; Organometallic Compounds; Salicylates | 2020 |
Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Drug Combinations; Drug Interactions; Magnesium Hydroxide; Male; Moxifloxacin; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Weightlessness; Weightlessness Simulation | 2021 |
74-Year-Old Woman With Chronic Diarrhea.
Topics: Aged; Antidiarrheals; Bismuth; Chronic Disease; Colitis, Microscopic; Diagnosis, Differential; Diarrhea; Female; Humans; Intestinal Mucosa; Organometallic Compounds; Salicylates | 2021 |
Bismuth subsalicylate incorporated in polycaprolactone-gelatin membranes by electrospinning to prevent bacterial colonization.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bismuth; Cell Survival; Cells, Cultured; Electrochemical Techniques; Fibroblasts; Gelatin; Gingiva; Guided Tissue Regeneration, Periodontal; Humans; Membranes, Artificial; Organometallic Compounds; Polyesters; Salicylates | 2021 |
Real-Time Observation of "Soft" Magic-Size Clusters during Hydrolysis of the Model Metallodrug Bismuth Disalicylate.
Topics: Bismuth; Organometallic Compounds; Salicylates | 2021 |
Structure of the active pharmaceutical ingredient bismuth subsalicylate.
Topics: Bismuth; Helicobacter Infections; Humans; Organometallic Compounds; Pharmaceutical Preparations; Salicylates | 2022 |
Bismuth Subsalicylate Poisoning.
Topics: Bismuth; Humans; Organometallic Compounds; Salicylates | 2022 |
Dual-Energy CT Reveals Bismuth Subsalicylate Overdose in Acute Appendicitis.
Topics: Acute Disease; Appendicitis; Bismuth; Humans; Salicylates; Tomography, X-Ray Computed | 2023 |